rfhg_41492.1

Basic information about the TSS

---

TSS ID: rfhg_41492.1 TSS ID(Version3): hg_34925.1 hg_228039.1 hg_34924.1 Species: human Chr: chr2		Start: 241508548 End: 241508641 Strand: -
Source datasets	FANTOM5|PRJNA401781|PRJNA548673|PRJNA615891|DRA013844 |PRJNA4843412
Protocol	CAGE|ReCappable-seq|SLIC_CAGE|TIF-seq2|NETCAGE
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3267705,EH38E2090730)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000316586.9:0 ENST00000405883.7:0 ENST00000405585.5:0 ENST00000442307.5:0 ENST00000429279.5:0 ENST00000452891.5:0 ENST00000483603.5:0 ENST00000436917.5:0 ENST00000495372.1:0 ENST00000426941.1:0 ENST00000420551.1:0 BC007852:0 BC091505:0 AK092161:0 AK291808:0 AK315966:0 AK301214:0 AK297374:0 AK291947:0 AK302751:0 GeneID: 10494 HGNC/MGI_ID: HGNC:11404 UniProt_ID: A0A024R4B2 A0A0S2Z4Y2 B3KRS6 B4DMA5 B4DVS7 B4DZ52 C9JCC0 C9JFA1 C9JJV0 C9JN58 Nearer transcript ids and distances:

Gene_name: STK25 Gene_symbol: STK25 Gene_synonyms: SOK1 YSK1 Gene_source: HGNC:11404

TATA-Box annotation

---

Distance to TSS:	-10
Nearest PromoterID:	NM_001271980
Entrez ID:	10494
Nearest Unigene:	Hs.516807
Nearest Refseq:	NM_006374
Nearest Ensembl:	ENSG00000115694
Gene Name:	STK25
Gene Alias:	SOK1|YSK1
Gene Type:	protein-coding
CpG%:	0.182796
GC%:	0.765957
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@STK25 p2@STK25 p3@STK25 p4@STK25 p5@STK25 p6@STK25 p7@STK25 p8@STK25
Sample		p1@STK25	p2@STK25	p3@STK25	p4@STK25	p5@STK25	p6@STK25	p7@STK25	p8@STK25
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.58	1.56	2.34	0.00	0.58	0.00	0.00	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.62	1.62	2.83	0.61	0.61	0.61	0.00	2.63
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	15.43	1.35	1.93	0.96	0.58	0.00	0.00	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	21.00	1.04	2.49	0.42	1.25	0.00	0.00	2.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.12	0.67	0.90	0.45	1.80	0.22	0.00	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	19.57	1.16	1.16	0.58	0.19	0.00	0.19	2.33
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.98	0.87	2.40	0.44	0.87	0.22	0.00	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	28.10	1.21	3.15	0.73	1.21	0.00	0.00	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	26.50	1.28	2.14	0.64	1.07	0.21	0.00	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	27.82	1.16	2.90	0.58	1.16	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.55	0.81	3.23	0.00	1.21	0.00	0.00	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	2.03	2.44	0.00	1.22	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	37.07	4.35	5.64	1.93	1.13	0.64	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.78	3.46	4.36	2.71	0.60	0.45	0.00	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.32	2.63	5.93	1.32	0.66	0.44	0.22	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.95	3.02	4.28	1.26	0.25	0.25	0.25	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.54	1.75	5.46	2.18	0.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	33.32	2.95	4.22	2.95	0.42	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	2.13	3.73	1.07	0.00	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	33.25	3.46	6.77	1.96	0.45	0.00	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.21	4.41	5.88	1.74	0.94	0.13	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.80	2.24	5.01	0.35	0.17	0.35	0.00	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	31.41	3.23	4.91	1.55	0.52	0.39	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	32.03	4.13	4.85	0.97	0.49	0.24	0.00	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.83	3.35	5.16	2.32	0.52	0.00	0.00	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	33.55	2.22	2.53	0.95	0.63	0.32	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	31.32	1.65	3.30	2.20	0.55	0.00	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.72	4.72	2.83	0.71	0.71	0.47	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.34	3.39	2.42	2.26	0.48	0.16	0.16	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	30.40	3.08	4.16	2.71	0.00	0.36	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.96	2.93	2.72	1.88	0.84	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.36	2.93	4.69	1.17	0.39	0.39	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	37.14	2.32	3.17	2.32	0.63	0.00	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.18	3.46	3.46	2.47	0.16	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	26.93	3.93	3.74	1.68	0.75	0.37	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.79	2.87	1.92	1.15	0.19	0.57	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	33.52	3.27	6.13	1.84	0.61	0.20	0.00	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.25	2.42	4.43	1.81	0.40	0.00	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	38.08	2.70	5.67	0.81	0.81	0.54	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.69	3.60	5.28	1.92	0.24	0.24	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.52	1.65	4.71	1.88	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.94	2.05	3.81	1.61	0.73	0.00	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	30.58	2.74	4.22	1.48	0.84	0.00	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	28.85	3.15	5.07	0.87	0.35	0.00	0.00	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	33.53	2.01	3.21	1.61	0.80	0.60	0.20	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	34.43	3.02	3.26	2.09	0.00	0.23	0.00	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	30.47	3.36	2.88	2.64	0.48	0.00	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	30.40	2.09	2.38	0.30	0.00	0.00	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	31.84	3.11	3.35	2.39	0.48	0.24	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.66	2.63	3.44	2.22	0.61	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.85	1.64	3.69	1.02	0.20	0.00	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.47	2.00	4.00	0.89	0.67	0.00	0.00	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	28.03	2.13	3.90	2.48	1.42	0.00	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	34.13	2.32	5.96	1.33	1.33	0.33	0.00	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	0.84	2.52	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.50	2.30	3.21	0.46	0.92	0.00	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	28.20	1.62	1.62	0.97	0.32	0.00	0.32	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.72	1.61	3.21	0.32	0.64	0.32	0.32	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	27.98	2.20	4.40	1.26	0.63	0.31	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	2.12	0.71	0.00	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	32.53	0.56	2.80	0.56	1.12	0.00	0.00	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	0.80	2.39	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.69	2.38	3.74	0.00	0.34	0.34	0.00	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.67	1.30	2.27	0.97	0.00	0.00	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.37	1.42	5.32	0.71	1.06	0.00	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	32.66	2.44	3.90	1.46	0.49	0.00	0.00	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.26	3.97	3.97	0.99	0.00	0.99	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.52	1.88	4.69	2.81	0.47	0.00	0.00	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.18	1.66	1.99	0.66	0.00	0.00	0.00	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.55	3.40	2.47	1.24	0.00	0.00	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.29	1.22	3.06	1.53	0.00	0.92	0.00	1.53
Adipocyte - breast, donor1	11376-118A8	38.80	1.90	2.69	1.11	0.16	0.32	0.32	1.43
Adipocyte - breast, donor2	11327-117E4	30.32	1.93	2.41	0.64	0.16	0.32	0.00	1.60
Adipocyte - omental, donor1	11473-119C6	33.33	1.91	3.18	1.65	0.25	0.13	0.51	1.78
Adipocyte - omental, donor2	11474-119C7	29.90	5.23	2.24	0.00	0.00	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	31.48	2.01	2.01	0.67	0.33	0.67	0.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	31.26	4.47	3.83	0.64	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	3.30	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.55	2.26	2.71	0.90	0.00	0.00	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	32.50	1.56	3.65	0.70	0.17	0.00	0.17	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	33.44	2.54	2.15	0.78	0.39	0.00	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	26.00	0.77	1.29	0.51	0.00	0.51	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	29.83	3.07	1.95	1.67	0.00	0.28	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	33.51	1.18	1.18	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	34.02	2.65	2.01	0.56	0.00	0.00	0.16	3.06
Adipocyte differentiation, day08, donor2	13023-139D8	27.43	2.58	1.94	0.32	0.00	0.00	0.00	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	1.60	1.60	0.00	0.00	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	26.15	0.56	1.67	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	34.10	3.33	1.66	0.42	0.00	0.42	0.83	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	23.61	0.00	1.00	0.50	0.25	0.00	0.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	26.83	1.96	0.65	0.00	0.00	0.00	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	22.53	0.30	0.61	0.30	0.00	0.00	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	70.50	13.04	8.40	5.08	1.10	0.88	0.66	2.87
Alveolar Epithelial Cells, donor2	11590-120G6	107.22	15.78	9.32	7.89	2.51	1.08	0.00	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	34.74	5.99	7.19	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	56.85	8.46	5.58	4.50	1.62	0.90	0.18	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	56.90	5.02	3.35	6.69	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	61.22	7.19	8.22	3.08	1.23	0.82	0.41	1.64
Anulus Pulposus Cell, donor1	11248-116E6	42.45	3.32	2.63	1.14	0.00	0.23	0.23	1.60
Anulus Pulposus Cell, donor2	11463-119B5	43.10	2.94	2.45	0.98	0.00	0.00	0.00	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	27.41	2.70	2.70	1.35	0.00	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	35.17	3.91	2.17	1.30	0.87	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	0.00	4.28	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	28.40	4.18	3.59	0.60	0.00	0.00	0.30	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	40.47	3.79	2.53	1.26	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	4.62	2.64	1.98	0.00	0.00	0.00	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	26.32	1.95	2.92	1.62	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	36.89	2.43	3.40	2.91	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.88	2.38	2.38	2.97	0.00	0.00	0.59	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	32.39	1.13	6.78	0.75	0.00	1.13	0.00	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	30.48	4.35	1.45	0.73	0.00	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	1.25	1.25	1.25	0.00	0.00	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	33.61	3.46	3.13	0.99	0.16	0.00	0.33	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	32.76	2.73	1.36	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	28.05	1.96	2.87	0.90	0.75	0.00	0.00	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	4.29	1.07	0.54	1.07	0.54	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.34	2.65	3.02	1.32	0.38	0.19	0.19	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	34.75	2.94	2.14	0.80	0.00	0.00	0.27	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	37.07	0.98	0.00	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.71	4.15	1.99	1.33	0.33	0.33	0.33	1.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	26.42	1.20	1.20	1.20	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	0.00	3.54	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	33.28	4.12	3.77	1.54	0.17	0.34	0.17	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.49	4.85	2.43	2.43	0.00	0.00	0.00	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.49	3.42	2.66	1.52	0.00	0.76	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	4.85	1.21	1.21	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	32.49	2.28	2.85	1.14	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.15	5.56	2.14	0.86	0.43	0.21	0.00	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.26	2.84	1.03	1.29	0.00	0.26	0.00	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.97	5.63	0.94	1.88	0.00	0.00	0.00	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	33.44	3.22	1.93	2.57	0.32	0.00	0.32	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	0.71	1.43	0.71	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	36.27	1.17	0.58	2.34	0.00	0.00	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	37.33	2.41	0.90	1.51	0.30	0.00	0.00	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	34.45	0.00	2.38	0.00	1.19	0.00	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.02	5.09	2.54	3.56	0.00	0.00	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.80	3.57	1.53	2.55	0.76	0.00	0.00	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	33.67	2.54	1.91	1.27	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	34.52	4.75	2.16	2.16	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.88	5.50	3.60	2.54	0.42	0.21	0.42	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	29.87	1.45	1.16	1.16	0.00	0.00	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	32.12	0.94	2.83	2.83	0.94	0.00	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.63	3.73	3.39	1.02	0.34	0.17	0.00	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	2.11	2.11	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	31.95	4.50	3.00	1.50	0.43	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	37.30	3.61	1.80	1.80	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	22.60	3.64	2.92	0.73	0.73	0.73	0.00	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.88	4.37	2.07	2.76	0.00	0.00	0.23	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	0.00	5.10	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.95	1.02	4.83	0.25	0.76	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.97	3.92	2.27	2.68	0.21	0.00	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.40	2.45	0.92	0.31	0.31	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.03	1.91	1.43	0.00	0.96	0.00	0.00	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.60	2.00	1.77	1.11	0.00	0.22	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	1.53	4.58	3.05	0.00	0.00	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.26	2.77	3.88	2.22	0.00	0.00	0.00	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.69	3.71	2.38	1.85	0.53	0.00	0.79	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.98	1.82	1.82	0.73	1.09	0.00	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	82.66	6.75	7.74	2.95	0.74	0.86	0.37	1.84
Astrocyte - cerebellum, donor2	11580-120F5	79.76	8.73	9.07	3.59	0.17	0.51	0.00	1.03
Astrocyte - cerebellum, donor3	11661-122F5	52.23	4.61	8.60	1.68	0.42	0.63	0.00	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	55.77	2.44	6.27	2.09	0.00	0.00	0.00	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	47.88	7.44	4.69	2.43	1.13	0.65	0.16	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	52.06	7.31	9.40	3.73	0.60	0.30	0.00	2.54
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	24.43	1.83	1.61	0.46	0.11	0.00	0.00	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	22.68	1.25	1.00	0.25	0.00	0.00	0.13	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	20.60	1.37	0.91	0.11	0.00	0.00	0.00	2.05
Basophils, donor1	12241-129G9	17.26	0.26	0.00	0.00	0.00	0.00	0.00	1.57
Basophils, donor2	12242-129H1	20.57	0.36	0.00	0.00	0.72	0.00	0.00	0.72
Basophils, donor3	12243-129H2	21.17	0.59	1.03	0.00	0.00	0.00	0.15	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	43.55	3.88	4.10	1.08	0.00	0.00	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	71.78	10.97	3.20	2.29	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	52.10	11.93	5.65	5.65	0.63	0.00	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	62.59	8.32	6.86	3.54	0.21	0.62	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	39.84	2.30	2.53	0.00	0.00	0.23	0.00	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	17.09	3.06	1.62	0.54	0.18	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	33.08	0.21	2.27	0.00	0.00	0.10	0.10	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	42.16	0.70	2.33	0.23	0.00	0.47	0.00	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.86	0.64	2.24	0.32	0.00	0.64	0.00	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	33.81	0.56	1.13	0.00	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	25.43	0.19	1.67	0.00	0.37	0.00	0.19	1.67
CD14+ Monocytes, donor3	11381-118B4	26.56	0.44	0.88	0.00	0.44	0.00	0.00	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	40.76	3.11	2.26	0.00	0.00	0.00	0.00	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.25	2.27	1.14	0.38	0.00	0.00	0.00	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	39.78	2.30	1.64	0.33	0.00	0.00	0.00	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	16.33	0.43	0.43	0.00	0.00	0.00	0.14	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	8.15	0.30	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	8.29	0.47	0.47	0.24	0.00	0.47	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.54	0.17	0.33	0.00	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.28	0.00	0.55	0.00	0.00	0.28	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.69	0.00	0.00	0.00	0.00	0.00	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.20	0.39	0.39	0.00	0.00	0.00	0.20	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.30	0.00	0.53	0.00	0.00	0.00	0.18	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.05	0.00	0.00	0.00	0.00	0.22	0.00	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	1.11	1.11	0.00	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.90	0.59	0.89	0.15	0.00	0.00	0.00	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.19	0.60	0.40	0.20	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.25	0.42	1.04	0.00	0.00	0.00	0.21	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.18	0.46	0.69	0.00	0.00	0.00	0.00	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.88	0.00	0.00	0.00	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.42	0.44	0.44	0.00	0.00	0.00	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	11.30	0.54	0.00	0.27	0.00	0.00	0.27	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.17	0.17	0.52	0.00	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.15	0.00	0.42	0.00	0.00	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.82	0.00	0.37	0.00	0.00	0.00	0.00	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.99	0.35	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.76	0.17	0.00	0.00	0.00	0.00	0.00	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	0.00	0.37	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.13	0.22	0.22	0.00	0.22	0.00	0.22	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.28	0.41	0.00	0.00	0.00	0.00	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.87	0.00	0.23	0.00	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.41	0.00	0.00	0.00	0.00	0.00	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	20.05	0.22	0.22	0.00	0.00	0.00	0.00	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	29.80	0.23	0.92	0.00	0.00	0.00	0.46	2.54
CD14+CD16+ Monocytes, donor3	11912-125G4	24.26	0.00	1.08	0.00	0.00	0.00	0.22	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	35.04	0.78	0.78	0.00	0.16	0.00	0.31	2.34
CD14+CD16- Monocytes, donor2	11799-124C8	34.06	0.17	0.87	0.00	0.00	0.00	0.00	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	25.86	0.45	1.11	0.00	0.00	0.00	0.00	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	26.79	0.00	0.77	0.00	0.00	0.00	0.51	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	25.25	0.00	0.22	0.00	0.00	0.00	1.10	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	21.05	0.00	1.05	0.00	0.00	0.00	0.42	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	4.06	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	45.42	2.71	2.03	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	37.28	1.04	1.04	0.00	0.00	0.00	0.00	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	39.44	1.07	1.60	0.00	0.00	0.00	0.00	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	41.28	0.54	0.54	0.00	0.00	0.00	0.00	5.36
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	43.52	2.11	0.70	2.11	0.00	0.70	0.00	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	40.00	3.92	1.57	0.00	0.00	0.00	0.00	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	2.64	3.95	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	31.23	0.82	0.00	0.82	0.00	0.00	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	32.64	2.90	1.45	1.45	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	29.78	1.01	0.50	0.00	0.00	0.50	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	50.51	0.81	2.83	0.00	0.40	0.00	0.81	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	54.33	0.40	2.40	0.40	0.00	0.00	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	20.08	0.00	0.00	2.01	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	16.85	0.00	0.00	1.12	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.59	3.76	4.51	2.25	0.75	0.00	0.00	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.10	3.38	4.28	1.58	0.68	0.68	0.45	2.71
CD4+ T Cells, donor1	11225-116C1	43.20	1.43	0.71	1.07	0.00	0.00	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	36.13	1.22	2.45	0.00	0.00	0.00	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	43.31	1.22	2.44	0.00	0.30	0.00	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.47	1.79	1.53	1.28	0.00	0.00	0.00	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	48.96	1.57	1.80	0.22	0.22	0.00	0.00	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	53.76	2.59	2.01	0.57	0.00	0.00	0.00	3.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	62.11	1.42	0.47	0.95	0.00	0.00	0.00	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	57.59	1.40	0.70	0.00	0.00	0.00	0.00	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	0.00	3.30	0.00	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	35.98	2.46	0.43	0.29	0.00	0.14	0.14	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	34.74	2.54	1.53	0.51	0.00	0.00	0.17	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	42.40	1.61	0.64	0.16	0.00	0.00	0.16	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	49.76	0.90	1.34	0.00	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.20	2.10	1.05	0.35	0.35	0.00	0.35	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.60	2.20	0.44	0.00	0.00	0.00	0.00	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	41.74	1.26	0.84	0.00	0.00	0.00	0.00	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	35.74	2.29	1.66	0.42	0.00	0.21	0.00	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	41.10	1.34	1.67	0.33	0.00	0.00	0.00	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	52.76	2.18	0.27	0.54	0.27	0.00	0.00	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	43.41	2.14	0.54	0.54	0.00	0.00	0.00	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	46.62	1.79	0.00	0.00	0.00	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	40.42	0.93	1.48	0.37	0.00	0.00	0.00	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	36.82	1.52	1.52	0.43	0.00	0.22	0.65	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	44.55	1.26	1.26	0.21	0.00	0.21	0.42	2.52
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.08	0.00	1.52	0.51	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	49.82	1.30	2.60	0.87	0.00	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	34.43	0.44	1.74	0.00	0.00	0.00	0.00	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	65.32	1.48	2.47	0.49	0.00	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	55.39	0.00	1.85	0.00	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	51.65	0.00	0.00	0.00	0.00	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	65.91	0.83	1.11	0.55	0.00	0.00	0.55	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	69.94	2.21	0.74	0.25	0.00	0.00	0.49	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	61.95	3.22	2.15	0.36	0.00	0.00	0.00	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	62.32	0.00	1.38	0.00	0.00	0.00	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	41.58	0.33	1.31	0.33	0.33	0.00	0.33	1.64
CD8+ T Cells, donor2	11307-117C2	34.54	1.50	1.13	0.00	0.00	0.00	1.13	2.25
CD8+ T Cells, donor3	11383-118B6	41.91	0.76	1.51	0.00	0.25	0.00	0.76	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.37	0.46	0.23	0.23	0.00	0.00	0.23	2.98
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.09	0.24	0.72	0.24	0.48	0.00	0.48	2.64
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.33	0.55	0.82	0.27	0.00	0.00	0.00	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.31	0.60	0.60	0.30	0.00	0.00	0.30	3.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.64	0.24	0.48	0.24	0.00	0.00	0.00	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.33	0.45	1.36	0.91	0.23	0.23	0.00	2.73
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.03	0.87	0.87	0.65	0.00	0.00	0.00	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.85	0.53	0.79	0.79	0.26	0.00	0.00	3.42
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.75	0.94	0.94	1.64	0.23	0.00	0.23	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.43	0.30	0.91	1.21	0.60	0.00	0.00	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.92	1.16	0.87	0.58	0.00	0.00	0.00	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.12	1.60	0.80	0.53	0.00	0.00	0.00	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.76	0.44	0.00	0.00	0.44	0.00	0.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	0.91	0.46	0.00	0.46	0.00	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	0.00	0.75	0.00	0.75	0.00	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.45	0.72	0.72	0.72	0.00	0.00	0.00	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.84	2.01	1.44	0.58	0.00	0.00	0.29	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.62	0.47	0.47	0.94	0.47	0.00	0.00	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.80	0.32	0.63	0.32	0.00	0.00	0.00	4.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.07	1.23	1.54	0.31	0.31	0.00	0.00	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.35	0.64	1.60	0.96	0.32	0.00	0.00	3.85
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.57	1.53	0.76	0.00	0.00	0.00	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.34	0.39	0.39	0.39	0.00	0.00	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.18	0.76	0.76	0.76	0.00	0.00	0.00	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	19.27	0.00	0.80	0.00	0.00	0.00	0.00	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	2.10	0.70	0.70	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	0.00	1.00	2.00	1.00	0.00	0.00	5.01
Cardiac Myocyte, donor1	11525-119I4	38.38	1.83	1.83	0.00	0.00	3.66	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	40.52	5.43	3.95	0.49	0.49	0.00	0.00	1.98
Cardiac Myocyte, donor3	11686-122I3	33.04	10.84	5.37	4.53	0.63	0.11	0.00	1.16
Chondrocyte - de diff, donor1	11261-116G1	37.44	2.08	5.20	1.39	0.00	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	36.60	2.13	1.42	0.00	0.71	0.71	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	32.88	2.28	4.21	1.02	0.11	0.11	0.23	1.25
Chondrocyte - re diff, donor2	11339-117F7	24.17	0.90	3.58	0.90	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	31.95	2.02	4.04	0.40	0.00	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	51.64	3.33	4.71	1.26	0.11	0.23	0.11	3.44
Ciliary Epithelial Cells, donor2	11323-117D9	42.11	6.41	5.34	2.35	0.21	0.64	0.21	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	45.40	3.45	4.69	2.74	0.18	0.27	0.00	2.12
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	52.82	2.57	3.48	0.83	0.18	0.37	0.64	4.31
Corneal Epithelial Cells, donor1	11526-119I5	63.90	3.73	4.83	1.54	0.00	0.22	0.22	1.10
Corneal Epithelial Cells, donor2	11606-120I4	50.05	2.28	7.96	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	44.22	4.09	3.32	1.02	0.26	0.00	0.00	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.61	1.65	0.00	1.16	0.00	0.00	0.00	1.65
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.02	0.95	0.32	0.95	0.00	0.00	0.00	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	20.09	1.84	1.51	1.19	0.00	0.11	0.11	1.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	22.89	1.37	0.34	0.68	0.00	0.00	0.00	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.20	1.31	1.31	0.00	0.00	0.00	0.00	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	3.87	1.45	0.48	0.00	0.00	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	35.69	7.84	6.84	10.01	2.50	0.50	0.00	3.67
Endothelial Cells - Aortic, donor1	11263-116G3	25.82	13.50	3.52	7.04	1.76	1.76	0.00	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	52.88	8.20	5.09	12.16	2.83	0.57	0.00	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	36.57	7.86	2.75	7.86	1.18	0.00	0.39	3.15
Endothelial Cells - Artery, donor1	11264-116G4	38.40	12.80	5.82	15.42	2.04	0.58	0.00	2.33
Endothelial Cells - Artery, donor2	11341-117F9	55.06	13.18	6.82	13.88	3.06	0.24	0.00	4.24
Endothelial Cells - Artery, donor3	11413-118E9	40.32	13.15	5.08	10.87	2.98	0.35	0.53	3.51
Endothelial Cells - Lymphatic, donor1	11236-116D3	36.13	6.43	4.43	11.30	1.77	1.11	0.00	3.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.82	8.82	5.48	6.69	0.91	0.30	0.00	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.32	11.28	6.48	8.74	1.97	0.00	0.28	2.54
Endothelial Cells - Microvascular, donor1	11265-116G5	55.27	16.05	2.38	17.53	2.97	0.30	0.00	4.46
Endothelial Cells - Microvascular, donor2	11342-117G1	29.68	8.85	3.12	3.12	2.60	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	51.19	14.32	8.22	29.63	2.84	0.14	0.00	4.25
Endothelial Cells - Thoracic, donor1	11266-116G6	51.62	10.00	9.60	11.20	1.60	0.40	1.20	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	41.41	13.63	6.81	12.05	1.57	1.57	0.00	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	55.41	7.58	6.71	10.06	1.49	0.37	0.25	4.47
Endothelial Cells - Umbilical vein, donor2	11324-117E1	44.32	7.17	5.65	8.47	0.65	0.43	0.22	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	52.27	8.06	7.82	8.67	0.85	0.37	0.00	2.32
Endothelial Cells - Vein, donor1	11267-116G7	48.91	19.34	5.69	13.65	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	51.69	13.27	2.79	10.48	4.19	0.70	0.00	3.49
Endothelial Cells - Vein, donor3	11416-118F3	44.90	17.27	5.65	12.09	3.14	0.31	0.00	2.36
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	0.00	1.65	0.00	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	37.38	2.20	5.13	1.22	0.49	0.49	0.00	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	54.08	0.00	6.24	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	41.05	3.28	3.69	0.41	0.00	0.00	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	21.02	1.53	0.99	0.77	0.44	0.11	0.00	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	39.00	1.95	2.38	1.63	0.00	0.11	0.00	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.29	3.52	2.30	2.43	0.24	0.36	0.00	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.81	3.00	3.14	0.27	0.41	0.41	0.82	3.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.17	4.32	4.43	2.43	0.11	0.21	0.11	1.58
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.52	0.79	3.69	0.00	0.26	0.00	0.00	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	34.88	4.32	4.32	1.33	0.00	0.00	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	36.29	4.99	3.18	3.63	0.00	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	52.30	12.89	3.03	3.03	0.76	0.00	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	37.06	7.89	3.00	3.79	0.16	0.00	0.00	2.05
Fibroblast - Cardiac, donor4	11452-119A3	34.25	3.33	4.24	2.73	0.30	0.30	0.00	1.52
Fibroblast - Cardiac, donor5	11456-119A7	42.39	4.95	3.05	2.16	0.51	0.13	0.25	0.89
Fibroblast - Cardiac, donor6	11460-119B2	33.05	5.76	1.97	2.43	0.45	0.45	0.15	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	51.05	4.15	3.48	0.80	0.00	0.13	0.13	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.20	4.75	3.88	0.43	0.00	0.00	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	7.32	8.79	5.86	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	64.35	3.23	3.23	1.85	0.23	0.00	0.00	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	48.34	2.54	3.05	1.02	0.00	0.17	0.17	1.70
Fibroblast - Dermal, donor1	11269-116G9	33.57	4.70	1.41	1.17	0.94	0.00	0.00	0.94
Fibroblast - Dermal, donor2	11346-117G5	33.96	2.36	4.25	4.72	0.47	0.94	0.00	1.42
Fibroblast - Dermal, donor3	11418-118F5	36.39	2.78	1.69	1.57	0.48	0.00	0.00	0.85
Fibroblast - Dermal, donor4	11450-119A1	49.06	4.41	3.05	3.50	0.45	0.00	0.00	1.24
Fibroblast - Dermal, donor5	11454-119A5	55.48	3.31	3.66	1.57	0.17	0.17	0.17	1.57
Fibroblast - Dermal, donor6	11458-119A9	59.93	5.36	3.74	3.09	0.49	0.16	0.00	1.62
Fibroblast - Gingival, donor1	11237-116D4	31.86	3.75	2.50	2.08	0.00	0.62	0.00	1.87
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	42.71	2.36	2.10	0.52	0.00	0.26	0.00	1.05
Fibroblast - Gingival, donor2	11318-117D4	47.31	3.03	3.56	2.64	0.26	0.00	0.26	1.71
Fibroblast - Gingival, donor3	11394-118C8	33.45	3.48	2.80	1.16	0.29	0.00	0.00	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	3.12	1.04	0.00	0.00	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.07	3.35	1.59	1.06	0.00	0.53	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	41.16	2.34	2.49	0.47	0.16	0.00	0.16	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.70	2.30	2.30	1.22	0.00	0.27	0.00	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.29	1.06	0.71	0.71	0.00	0.00	0.35	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	41.97	2.34	2.34	1.61	0.15	0.15	0.00	1.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	34.22	1.09	3.14	0.95	0.68	0.00	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	43.11	1.65	2.19	1.65	0.11	0.44	0.11	1.65
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.14	1.91	3.67	1.91	0.15	0.00	0.00	0.73
Fibroblast - Lung, donor1	11270-116H1	40.78	6.80	1.36	0.00	0.00	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	40.29	2.98	2.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	51.70	4.22	3.80	1.27	0.84	0.42	0.00	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	71.64	4.17	2.50	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	46.15	4.20	4.20	1.40	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	48.98	3.36	1.68	1.96	0.28	0.56	0.28	1.96
Fibroblast - Mammary, donor1	11540-120B1	56.43	6.09	3.65	2.03	0.41	0.00	0.00	2.84
Fibroblast - Mammary, donor2	11620-122A9	87.87	3.99	7.99	0.00	0.00	0.00	0.00	7.99
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	5.96	0.00	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.20	3.10	4.85	1.75	0.39	0.19	0.00	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.97	3.34	3.79	1.97	0.30	0.15	0.00	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.88	6.43	2.14	2.75	0.00	0.00	0.31	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	40.83	2.67	3.05	0.76	0.00	0.00	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	46.98	3.78	4.32	1.89	0.54	0.00	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.17	1.86	2.67	1.28	0.00	0.12	0.00	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	44.21	5.20	3.21	2.98	0.33	0.00	0.11	3.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	60.14	3.25	3.05	2.24	0.20	0.00	0.00	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	74.84	3.34	3.34	2.00	0.00	0.00	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	33.61	4.74	3.56	1.19	0.40	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	55.57	3.57	2.98	1.39	0.00	0.00	0.20	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.77	2.31	4.09	1.07	0.18	0.36	0.18	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	40.40	2.17	1.58	2.76	0.00	0.00	0.00	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	61.07	2.41	3.01	0.30	0.00	0.00	0.30	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	40.59	2.70	2.48	1.40	0.00	0.11	0.11	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	60.99	3.04	4.30	0.76	0.51	0.00	0.25	1.52
Fibroblast - skin normal, donor1	11553-120C5	41.18	3.94	2.79	0.98	0.16	0.00	0.00	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	50.53	2.01	3.41	2.01	0.40	0.20	0.20	2.61
Fibroblast - skin normal, donor2	11561-120D4	48.22	4.82	2.31	2.41	0.10	0.20	0.10	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	70.42	2.72	6.04	0.91	0.91	0.00	0.30	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	43.74	1.74	2.90	0.99	0.08	0.17	0.00	1.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	43.59	2.74	2.91	0.17	0.17	0.00	0.00	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	45.98	1.64	1.97	0.99	0.33	0.00	0.00	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	42.50	3.52	2.24	1.81	0.11	0.21	0.11	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	42.84	4.89	4.22	1.69	0.17	0.17	0.00	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.58	1.57	3.29	0.94	0.00	0.00	0.00	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	1.74	5.23	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	41.78	6.07	2.25	2.77	1.04	0.17	0.00	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	43.98	7.81	6.25	3.12	0.78	0.00	0.00	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	44.46	10.22	4.34	4.09	1.02	0.26	0.00	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	51.29	4.59	11.48	0.00	0.77	0.77	0.00	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	47.22	1.28	12.12	1.91	0.00	1.28	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	74.74	2.28	16.26	1.43	1.14	1.14	0.00	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	100.10	0.55	15.99	0.28	0.28	1.38	0.00	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	61.88	2.05	6.85	0.46	0.23	0.68	0.00	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	75.49	2.58	14.07	1.98	0.40	1.39	0.00	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	90.40	0.26	15.07	0.79	0.00	1.85	0.00	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	75.01	1.30	6.85	1.30	0.98	0.98	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	57.49	1.33	12.38	0.88	0.44	1.77	0.00	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	50.17	1.98	8.48	1.13	0.57	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	49.63	3.08	7.88	0.49	0.37	0.74	0.12	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	44.59	2.95	6.98	1.61	0.27	0.54	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	57.61	5.33	6.94	2.35	0.12	1.61	0.00	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.20	5.26	9.14	3.18	0.00	1.52	0.00	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	39.24	3.86	5.69	3.66	0.41	1.63	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.53	6.39	9.36	2.97	0.46	1.14	0.00	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.98	5.61	5.23	3.74	0.25	0.87	0.25	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	44.81	5.03	5.25	3.72	0.87	0.00	0.00	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	57.03	3.84	11.52	2.07	0.00	1.48	0.00	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	52.30	2.86	9.06	1.91	0.32	0.32	0.00	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	50.49	4.92	5.81	3.13	0.22	0.67	0.00	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	56.66	4.23	8.47	1.61	0.20	1.01	0.00	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.79	2.88	5.26	1.02	0.17	1.19	0.00	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	61.54	5.05	7.63	2.57	0.44	0.35	0.18	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	80.85	4.58	10.20	2.39	0.10	1.98	0.00	1.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	71.04	4.10	8.20	2.56	0.17	0.51	0.00	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	52.34	3.32	7.41	1.99	0.11	1.00	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.90	4.08	9.40	2.58	0.25	0.92	0.17	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.64	3.88	5.31	1.02	1.02	0.00	0.00	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	55.50	3.92	8.87	0.83	0.21	0.83	0.00	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	56.95	3.46	6.57	0.92	0.35	1.15	0.12	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.36	3.84	7.67	0.67	0.00	1.00	0.00	2.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	59.74	3.31	9.48	1.10	0.00	0.88	0.00	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	53.13	2.71	6.40	1.84	0.12	1.23	0.00	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.52	4.54	7.13	1.30	0.00	1.46	0.00	1.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	60.29	3.21	6.74	0.96	0.32	0.00	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	48.70	3.60	7.11	1.04	0.28	0.85	0.28	1.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.02	4.27	4.75	2.21	0.00	0.00	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	52.00	3.95	6.69	1.52	0.00	1.22	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	47.67	3.03	4.91	1.78	0.10	0.73	0.10	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	47.20	3.07	3.95	0.88	0.00	0.66	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	51.06	5.05	5.33	0.56	0.00	0.00	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	43.15	3.80	5.00	1.57	0.09	0.28	0.00	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.52	5.35	3.74	1.60	0.00	0.80	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.64	5.05	5.66	2.30	0.31	0.77	0.15	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.92	4.15	4.27	2.72	0.26	0.13	0.00	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	42.29	2.44	6.51	1.63	0.27	0.27	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	42.95	4.42	5.16	2.58	0.00	0.92	0.00	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	42.77	5.04	7.90	0.88	0.00	0.44	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	3.97	3.97	0.00	0.00	0.99	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.17	5.01	5.01	2.11	0.00	0.66	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	48.83	4.84	5.45	1.41	0.40	0.20	0.00	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.72	3.56	2.80	1.52	0.00	0.00	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	51.36	4.38	10.75	2.39	0.00	1.39	0.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.84	1.54	9.40	1.08	0.15	0.92	0.00	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	63.42	1.84	11.46	0.41	0.41	0.61	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	48.50	3.44	11.27	0.94	0.94	1.25	0.00	2.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	48.32	1.70	8.48	1.70	0.28	1.70	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	60.42	2.77	7.38	3.23	0.46	0.92	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	2.47	9.90	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	49.51	2.32	9.28	2.71	0.39	1.16	0.00	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	38.51	4.81	4.81	0.00	3.21	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	1.74	8.69	0.00	0.00	1.74	0.00	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	51.10	2.60	12.04	1.95	0.65	0.33	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.53	4.12	7.00	0.41	0.41	0.82	0.00	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	0.00	10.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	48.38	3.64	7.27	2.80	0.28	1.12	0.00	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	51.64	2.94	10.46	1.63	0.98	1.31	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	60.40	1.68	13.42	0.84	0.00	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	59.48	2.54	8.27	2.23	0.64	0.32	0.00	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	48.91	5.77	6.79	1.70	0.68	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	62.64	2.09	10.44	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	75.02	6.30	15.46	1.72	0.57	1.72	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	52.39	5.62	12.14	0.89	0.30	0.30	0.30	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	45.74	1.69	5.08	1.69	1.69	3.39	0.00	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.75	4.56	6.63	1.66	0.00	1.66	0.00	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	53.62	3.22	11.74	1.15	0.46	2.07	0.23	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	5.27	15.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	49.59	1.92	9.61	0.77	0.38	0.38	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	50.20	5.87	9.13	1.30	0.33	0.33	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	49.49	2.68	7.36	1.34	0.00	0.00	0.00	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	59.33	5.01	12.33	0.77	0.00	0.39	0.00	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	66.07	3.08	8.56	1.03	1.03	1.03	0.00	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	82.00	14.91	7.45	0.00	4.97	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	63.23	0.47	12.27	0.47	0.00	0.94	0.00	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.18	4.83	7.85	0.00	0.00	0.00	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	61.55	3.05	9.66	0.51	0.51	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	59.03	2.79	11.97	1.20	0.00	0.80	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	64.63	1.97	10.85	0.99	0.00	0.99	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	2.36	17.71	0.00	1.18	1.18	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	66.51	4.08	10.50	0.58	0.58	1.17	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	53.10	1.76	7.46	0.44	0.88	0.44	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	58.49	2.54	8.48	0.85	0.00	0.85	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	65.66	1.79	8.36	1.19	0.00	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.73	2.91	4.37	0.49	0.00	0.97	0.97	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	2.28	1.14	0.00	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	44.08	8.32	5.41	2.49	0.00	0.00	0.00	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	48.35	0.00	3.37	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	33.62	0.63	3.17	0.63	0.32	0.95	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.56	3.76	2.51	1.67	0.42	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.28	4.06	2.44	1.04	0.58	0.12	0.00	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.24	2.19	2.19	1.52	0.00	0.34	0.00	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	19.79	3.64	2.28	0.68	0.00	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.42	4.26	1.31	1.31	0.55	0.22	0.00	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.28	4.73	1.72	1.07	0.21	0.00	0.21	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.15	3.44	1.08	0.43	0.22	0.00	0.00	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.28	3.99	1.25	1.87	0.37	0.37	0.00	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.90	3.43	2.06	1.03	0.51	0.17	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	19.54	3.84	1.60	0.96	0.64	0.00	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	53.72	8.95	5.60	12.31	0.56	0.56	0.00	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	50.64	4.33	4.33	6.92	1.30	0.87	0.00	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	7.93	7.93	7.93	2.64	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	75.84	6.70	7.05	4.94	1.06	0.00	0.00	4.23
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	68.29	6.54	8.72	1.45	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	28.32	5.77	4.20	2.80	0.35	0.70	0.00	1.40
Hepatocyte, donor1	11523-119I2	32.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	28.01	0.00	5.39	1.08	1.08	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	33.13	1.23	2.45	0.61	0.00	0.00	0.00	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	29.37	0.00	1.31	0.00	0.65	0.00	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	14.68	2.27	4.02	1.22	0.17	0.70	0.00	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	35.54	6.31	3.16	3.29	0.41	0.14	0.00	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	12.74	6.37	3.18	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	73.43	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	2.77	4.15	2.77	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	55.06	0.00	7.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	2.56	2.56	0.00	2.56	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	47.11	8.12	4.87	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	1.67	1.67	0.00	0.00	0.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	3.63	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	38.38	1.32	1.32	1.32	2.65	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	34.37	3.33	1.11	0.00	2.22	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	0.00	0.00	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	41.57	1.89	1.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	1.55	1.55	3.09	0.00	0.00	0.00	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	41.99	5.17	1.94	0.00	0.65	0.00	0.00	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	1.61	9.66	0.00	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	47.26	2.44	4.07	0.00	0.81	0.81	0.00	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	46.18	2.10	0.84	0.84	1.26	0.84	0.00	3.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	33.75	2.41	1.61	1.61	0.80	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	35.08	2.77	0.00	3.69	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	29.74	1.89	1.89	2.36	0.00	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.02	3.63	3.63	0.00	0.91	0.00	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	46.27	1.08	3.23	0.00	0.00	0.00	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	33.03	1.27	2.54	1.27	0.00	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.07	0.64	3.19	0.00	0.64	0.64	0.00	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	36.45	1.82	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	36.42	2.86	2.14	2.86	0.00	0.00	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	0.00	0.00	3.32	0.00	0.00	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	28.09	2.47	1.54	2.47	1.85	0.31	0.00	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	47.41	1.76	1.76	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	47.15	3.14	3.14	0.00	0.00	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	2.78	2.09	2.09	0.00	0.70	0.00	5.56
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	4.43	2.21	2.21	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	71.50	2.62	0.87	0.87	2.62	0.00	0.00	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	53.99	9.00	2.25	0.00	0.00	0.00	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	3.48	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	66.14	3.20	4.27	1.07	0.00	0.00	0.00	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	44.33	4.16	5.54	2.77	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	0.00	0.00	0.00	0.00	0.00	8.55
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	51.54	2.76	5.52	0.92	2.76	0.00	0.00	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	9.08	0.00	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	68.73	1.06	3.17	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	35.09	3.18	2.94	1.55	0.41	0.33	0.08	0.73
Keratinocyte - epidermal, donor2	11349-117G8	39.82	2.93	1.17	0.59	0.00	0.00	0.00	1.76
Keratinocyte - epidermal, donor3	11421-118F8	36.73	4.16	5.49	1.42	0.09	0.19	0.00	0.38
Keratinocyte - oral, donor1	11251-116E9	43.93	3.06	6.13	1.36	0.00	0.11	0.00	0.57
Keratocytes, donor1	11527-119I6	38.17	2.75	3.78	2.41	0.00	0.00	0.00	1.03
Keratocytes, donor2	11607-120I5	41.01	2.34	2.34	3.52	0.00	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	24.50	0.20	0.79	0.40	0.00	0.00	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	47.46	6.47	5.39	0.00	1.08	0.00	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	46.25	3.81	4.61	2.19	0.12	0.35	0.00	1.38
Lens Epithelial Cells, donor3	11690-122I7	29.06	4.04	2.52	2.52	0.40	0.00	0.10	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	38.30	9.49	4.39	10.20	1.19	0.36	0.00	3.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	33.77	3.35	4.47	6.70	0.56	0.28	0.00	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.62	4.72	3.46	5.67	0.79	0.31	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	33.88	6.45	3.23	3.23	1.08	0.00	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.30	2.84	3.47	2.84	1.58	0.32	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.85	3.99	3.67	7.12	0.65	0.22	0.11	2.16
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.88	2.46	3.28	4.51	0.82	0.41	0.00	2.46
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	35.14	3.54	3.29	5.56	1.26	0.25	0.25	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.53	4.93	3.94	4.93	0.56	0.42	0.00	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	25.71	4.35	2.77	5.14	0.00	0.00	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	31.80	5.82	4.07	6.20	0.39	0.19	0.00	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	36.47	6.30	2.96	6.30	1.67	0.37	0.00	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.45	3.83	2.44	6.62	1.39	0.35	0.00	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.19	5.01	5.25	6.44	1.43	0.24	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.86	4.12	2.33	7.00	0.55	0.27	0.14	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	23.10	1.85	1.54	4.93	1.23	0.00	0.00	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.12	4.36	0.94	4.68	0.62	0.31	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.56	4.76	1.83	7.14	0.18	0.18	0.18	2.01
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.25	4.28	3.62	3.62	0.99	0.66	0.00	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.29	2.64	2.93	3.22	0.29	0.29	0.29	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	33.11	3.49	2.99	4.98	1.24	0.25	0.00	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	25.70	2.91	2.42	4.85	0.97	0.48	0.00	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.89	3.23	1.62	5.92	0.81	0.54	0.00	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	39.06	3.78	3.48	4.69	0.91	0.45	0.00	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.70	3.63	0.52	1.56	0.52	0.00	0.00	4.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.90	3.56	3.14	4.61	0.21	0.63	0.00	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	32.48	4.21	1.65	4.21	0.60	0.15	0.30	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.70	1.38	2.75	4.82	0.69	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	27.28	2.45	2.45	7.34	0.75	0.38	0.00	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.73	3.82	2.86	7.53	1.06	0.32	0.00	2.44
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.48	2.42	2.42	7.27	0.97	0.48	0.00	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.17	2.32	1.98	4.30	1.32	0.00	0.33	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.71	4.34	3.47	6.81	0.99	0.37	0.12	1.36
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.02	1.48	1.85	7.03	1.48	0.74	0.00	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.25	2.22	2.22	3.95	0.74	0.00	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	31.07	5.22	1.92	5.36	0.96	0.27	0.00	1.79
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	29.91	3.86	3.22	8.36	0.96	0.00	0.00	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	23.74	2.13	2.74	3.35	0.61	0.00	0.00	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	32.33	5.32	3.22	4.90	0.84	0.14	0.00	3.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.29	3.91	2.13	5.33	2.13	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.00	5.82	2.42	5.33	0.97	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	37.66	5.14	2.80	6.54	1.71	0.47	0.31	2.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.45	3.22	1.43	3.22	1.43	0.36	0.00	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.11	3.59	5.55	5.55	0.00	0.00	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	31.78	5.18	3.30	5.18	0.24	0.00	0.00	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	39.60	8.29	3.59	7.55	1.24	0.12	0.12	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.87	5.12	2.56	6.66	0.77	0.26	0.26	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	28.64	5.07	2.98	5.67	0.60	0.30	0.30	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	4.53	4.53	2.27	0.00	0.00	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	45.26	3.84	2.30	1.53	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.88	1.48	0.74	0.00	0.00	0.00	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	46.97	1.69	4.65	0.85	0.85	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.09	2.81	3.52	0.00	0.00	0.00	1.41	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	33.62	0.93	0.93	0.00	1.87	0.00	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	31.95	1.03	1.55	0.00	0.00	0.00	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	42.82	1.19	2.38	2.38	1.19	0.00	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.60	2.94	3.17	0.45	0.00	0.68	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.90	1.45	3.20	1.16	0.00	0.00	0.87	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	1.80	2.70	0.45	0.00	0.90	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	44.17	1.76	5.55	0.68	0.27	0.68	0.27	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.54	1.54	1.54	1.03	0.00	0.00	0.51	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	30.35	0.71	2.12	0.35	0.00	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.32	2.00	3.33	0.67	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.17	2.55	4.58	1.02	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	32.02	3.20	4.00	0.80	0.00	0.27	0.80	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.85	1.70	3.40	1.13	0.00	0.38	0.38	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	34.97	2.45	3.07	0.61	0.00	0.61	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	0.82	5.71	1.63	0.82	1.63	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.15	1.46	4.16	0.42	0.42	0.42	0.42	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.31	0.56	2.80	0.56	0.28	0.00	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	41.21	1.03	2.06	1.03	0.00	1.03	0.00	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	35.42	2.03	2.32	0.87	0.29	0.29	0.58	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.96	1.49	3.59	0.60	0.30	0.00	0.00	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	32.09	2.21	2.77	0.55	0.00	0.00	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	36.41	2.47	5.30	1.77	0.71	0.00	0.35	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	38.35	0.74	3.32	0.74	0.00	0.37	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	0.00	2.30	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	46.82	2.30	3.84	1.15	0.00	0.00	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	41.89	2.26	2.83	0.57	0.00	0.57	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	36.92	3.28	2.46	0.82	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	37.51	1.81	6.33	1.36	0.00	0.00	0.45	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	32.32	2.15	0.00	0.00	0.00	0.72	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.86	1.49	1.49	0.75	0.00	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	43.85	1.86	4.46	1.86	0.00	0.74	0.74	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.00	3.02	3.88	0.86	0.43	0.86	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	40.25	4.28	4.28	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	36.65	2.00	4.33	1.33	0.00	0.33	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.20	1.81	3.02	1.21	0.00	0.00	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	40.53	4.27	0.71	0.71	0.00	0.71	0.00	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.03	4.47	5.84	1.37	0.34	0.34	0.34	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	35.43	2.68	2.15	0.54	1.07	1.07	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	39.73	4.71	2.69	3.37	0.00	0.00	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	38.15	2.22	4.07	0.37	1.11	0.37	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	33.72	3.49	4.65	1.16	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	42.31	2.12	6.35	0.00	0.00	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	38.01	0.80	3.60	0.00	0.00	0.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.07	0.00	5.81	0.00	0.00	0.73	0.73	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	46.76	3.07	3.83	0.00	1.53	2.30	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	48.83	0.49	6.41	0.49	0.00	0.00	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	51.75	0.00	1.88	0.00	0.00	0.94	0.00	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	42.24	4.53	4.02	2.01	0.00	0.50	0.00	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	39.65	2.70	3.15	0.45	1.35	0.00	0.45	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	0.00	1.72	0.00	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	36.52	3.12	3.56	1.78	0.00	0.00	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	42.62	3.13	3.91	0.00	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	1.98	1.32	0.66	0.66	0.00	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	41.51	2.59	2.59	0.52	0.00	0.00	0.52	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.94	2.63	5.69	0.44	0.44	0.44	0.88	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	32.99	1.68	3.91	0.00	1.12	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	36.66	2.21	6.18	1.32	0.00	0.44	0.88	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	33.17	2.70	3.47	0.77	0.00	0.77	0.00	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.87	2.03	1.52	1.01	0.00	0.00	0.00	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.60	3.36	2.88	1.92	0.00	0.48	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.57	1.99	4.37	1.19	0.00	0.00	0.00	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	30.38	0.61	1.82	0.61	0.00	0.00	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	40.12	3.46	0.00	1.38	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	37.62	2.28	2.66	1.90	1.14	0.76	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	38.73	0.52	3.10	1.03	0.00	0.00	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	42.93	1.81	6.65	1.21	1.21	0.60	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	35.49	2.85	2.22	0.32	0.95	0.32	1.27	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	37.85	1.07	3.73	0.53	0.00	0.53	0.00	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	48.27	1.72	0.57	0.00	1.15	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	38.05	3.09	2.57	0.00	0.51	1.03	0.00	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.95	3.54	3.54	0.71	0.71	0.71	0.71	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	48.80	5.11	4.54	1.13	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.11	1.66	2.91	1.25	0.42	0.42	0.00	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	40.72	0.78	1.57	1.57	2.35	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	42.17	2.09	4.18	2.09	0.42	0.84	1.67	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	31.13	1.86	7.90	1.86	1.39	0.00	0.00	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	36.80	2.01	2.01	1.34	0.67	0.00	0.00	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	43.31	3.74	1.60	2.67	0.00	0.53	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.58	4.85	4.45	1.21	0.81	0.40	1.21	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	28.45	0.92	3.67	1.84	0.00	0.00	0.00	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	48.01	0.89	2.67	0.89	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	44.45	3.99	3.42	2.28	1.14	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	48.31	5.37	3.07	0.00	2.30	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.94	1.64	1.09	1.09	0.00	0.55	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	44.10	4.01	7.57	0.89	0.45	0.00	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	38.99	2.60	4.68	1.56	0.26	0.26	0.78	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	45.75	1.33	3.98	0.66	1.33	1.33	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	0.00	6.24	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	26.67	1.37	1.14	0.00	0.00	0.00	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	17.80	1.10	0.92	0.18	0.00	0.00	0.00	1.10
Macrophage - monocyte derived, donor3	11389-118C3	22.15	1.18	0.79	0.79	0.13	0.00	0.00	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	6.90	4.78	2.66	1.06	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	33.27	7.13	3.80	2.69	1.11	0.48	0.00	0.79
Mallassez-derived cells, donor3	11930-125I4	36.69	5.42	3.06	2.50	0.42	0.28	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	29.99	2.59	2.89	1.20	0.10	0.10	0.10	1.10
Mammary Epithelial Cell, donor2	11350-117G9	30.98	3.76	2.03	2.90	0.58	0.00	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	47.64	5.24	4.49	1.75	0.00	0.25	0.00	0.75
Mast cell - stimulated, donor1	11487-119E2	9.49	0.00	0.00	0.68	0.68	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	24.55	1.95	0.43	0.54	0.11	0.00	0.22	0.87
Mast cell, donor2	11565-120D8	34.77	2.08	0.59	1.19	0.00	0.00	0.00	2.67
Mast cell, donor3	11566-120D9	37.82	1.13	0.68	0.68	0.00	0.23	0.23	2.03
Mast cell, donor4	11567-120E1	39.00	1.60	2.13	1.60	0.18	0.18	0.18	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	30.05	0.11	0.89	0.00	0.00	0.00	0.11	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	36.77	0.58	0.58	0.00	0.00	0.00	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	38.09	0.69	0.69	0.46	0.11	0.23	0.23	2.41
Mast cell, expanded, donor8	11941-126A6	39.16	0.67	1.67	0.33	0.17	0.00	1.17	3.01
Melanocyte - dark, donor1	11502-119F8	45.07	15.22	3.48	13.73	1.39	0.20	0.00	3.78
Melanocyte - dark, donor2	11582-120F7	33.22	4.50	2.08	2.08	0.00	0.69	0.00	1.04
Melanocyte - dark, donor3	11663-122F7	32.60	4.42	3.48	2.68	0.36	0.36	0.07	0.43
Melanocyte - light, donor1	11274-116H5	30.79	4.47	3.53	0.94	0.24	0.00	0.00	0.47
Melanocyte - light, donor2	11351-117H1	34.12	2.05	4.09	2.05	0.00	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	22.55	3.47	4.34	2.60	0.00	0.00	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	43.84	3.64	4.89	1.35	0.10	0.62	0.10	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	26.89	1.88	2.69	0.81	0.00	0.00	0.54	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	30.00	1.34	2.14	1.07	0.27	0.00	0.00	1.34
Meningeal Cells, donor1	11493-119E8	65.26	3.47	3.60	1.61	0.50	0.37	0.12	1.74
Meningeal Cells, donor2	11573-120E7	62.50	3.96	2.20	1.76	0.44	0.00	0.00	1.76
Meningeal Cells, donor3	11654-122E7	38.31	2.61	2.20	1.06	0.00	0.08	0.08	1.96
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	47.05	4.28	4.28	1.14	0.00	0.00	0.00	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.37	2.82	2.21	1.41	0.60	0.10	0.00	1.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	86.73	9.20	6.57	2.63	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	73.26	5.23	9.16	3.92	0.00	0.00	0.00	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	52.39	2.15	4.31	2.15	0.72	0.00	0.00	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	33.25	3.18	1.48	0.85	1.06	0.00	0.21	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	39.71	1.51	2.51	1.01	0.50	0.50	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	51.64	3.52	3.52	1.98	0.22	0.00	0.00	2.86
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	48.95	2.92	3.65	1.46	0.00	0.00	0.00	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	60.97	6.14	4.71	3.07	0.41	0.41	0.20	2.05
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	42.66	1.94	2.63	0.69	0.14	0.14	0.00	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	67.28	3.72	5.95	1.49	0.37	0.37	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	40.66	1.58	3.42	1.32	0.26	0.26	0.13	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	37.69	2.08	4.15	0.89	0.00	0.30	0.00	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	0.00	7.01	4.67	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	46.11	3.20	5.12	2.56	0.64	0.64	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	49.98	4.61	2.84	3.54	0.35	0.35	0.35	4.96
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.59	3.44	2.81	1.88	0.00	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	45.72	2.18	3.63	2.18	0.73	0.00	0.00	2.90
Mesothelial Cells, donor1	11247-116E5	33.15	3.45	2.65	0.53	0.00	0.00	0.27	2.92
Mesothelial Cells, donor2	12156-128G5	28.03	8.51	6.51	2.00	1.00	0.00	0.00	2.50
Mesothelial Cells, donor3	11402-118D7	30.64	3.69	2.46	0.87	0.14	0.14	0.07	1.81
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	0.00	0.00	0.00	0.00	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.69	1.72	0.74	0.74	0.00	0.00	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.02	0.88	0.29	1.18	0.00	0.29	0.29	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.29	1.86	0.00	0.00	0.00	0.00	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.73	0.83	0.62	0.41	0.00	0.00	0.00	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	0.00	2.32	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.27	2.00	0.25	0.75	0.00	0.00	0.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.48	0.00	0.47	0.00	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.74	2.44	0.81	0.20	0.00	0.00	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	1.19	0.40	0.00	0.00	0.00	0.00	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	0.88	0.88	0.00	0.00	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.86	1.52	0.00	1.14	0.00	0.00	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	0.00	0.00	0.00	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.25	2.12	0.64	0.64	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	0.00	0.00	0.00	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.31	0.89	0.00	0.60	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.30	1.51	0.25	0.50	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.93	0.71	0.24	0.95	0.00	0.00	0.00	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.93	1.11	0.55	0.55	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	1.38	0.23	0.00	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.73	0.63	0.21	0.84	0.21	0.00	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.97	1.02	0.82	0.41	0.00	0.00	0.00	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.95	1.50	0.64	0.00	0.00	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.00	0.89	0.00	0.89	0.22	0.00	0.00	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.01	0.00	0.22	1.10	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	1.01	0.51	0.51	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.51	1.09	0.54	0.54	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.29	1.47	0.59	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	0.00	0.00	0.00	0.00	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.25	1.44	0.00	1.92	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	0.80	0.80	0.80	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	0.00	1.37	1.37	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.02	0.00	0.00	1.00	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	0.88	0.00	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	0.00	2.21	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	1.92	0.64	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.42	1.74	0.25	0.50	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	2.78	0.00	2.78	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00	0.00	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.99	1.37	0.68	1.03	0.00	0.00	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.88	0.44	0.00	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.33	0.36	1.07	0.00	0.00	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.96	2.81	0.56	0.56	0.00	0.00	0.00	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.13	0.83	1.25	0.42	0.00	0.00	0.00	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	0.00	0.58	0.00	0.58	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	1.51	1.21	0.30	0.30	0.30	0.00	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.52	0.00	0.00	1.67	0.00	0.00	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.24	0.57	0.57	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.47	0.14	0.69	0.14	0.00	0.00	0.00	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.22	1.04	0.52	1.55	0.00	0.00	0.00	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.44	0.43	1.72	0.00	0.00	0.00	0.00	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.79	0.00	1.27	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.34	1.07	1.07	0.27	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.16	0.60	1.20	0.90	0.00	0.00	0.30	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.98	0.71	0.28	0.00	0.00	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	2.23	0.32	0.00	0.00	0.32	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.80	1.11	0.44	1.33	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.55	0.38	0.38	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.08	0.85	0.85	0.28	0.00	0.00	0.28	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.68	1.23	0.98	0.74	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	0.00	0.65	0.00	0.00	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.82	1.47	0.00	0.29	0.00	0.00	0.29	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.89	1.44	1.73	0.29	0.00	0.00	0.29	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.37	0.82	0.41	0.41	0.00	0.00	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.16	1.79	0.30	0.30	0.00	0.00	0.00	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	0.00	0.00	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	25.30	2.63	0.33	0.66	0.00	0.00	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.14	0.99	0.99	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	0.93	1.86	0.00	0.00	0.93	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	1.50	1.88	0.38	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	29.03	2.13	0.27	0.80	0.00	0.00	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.10	1.70	1.36	0.23	0.00	0.00	0.23	1.24
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	2.21	0.74	0.74	0.00	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	0.73	0.73	0.37	0.00	0.00	0.00	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	3.11	0.00	0.00	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	1.07	0.53	0.00	0.00	0.00	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	26.26	0.00	2.02	0.00	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	0.42	1.26	0.42	0.42	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	35.55	7.32	3.02	3.66	0.43	0.22	0.22	2.59
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.29	2.61	4.70	2.09	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	31.37	4.00	0.00	3.34	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	24.21	1.25	3.76	1.25	0.00	0.42	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.44	2.47	3.23	1.52	0.00	0.00	0.00	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	73.41	3.19	3.19	1.60	1.60	0.00	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	20.40	0.68	2.04	0.00	0.00	0.00	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	3.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	23.86	1.67	1.26	0.84	0.00	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.45	2.32	1.86	1.16	0.93	0.70	0.23	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.35	0.54	1.62	2.16	0.27	0.00	0.81	2.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	36.79	1.89	1.26	0.63	0.21	0.00	0.00	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	36.23	0.50	0.99	0.00	0.00	0.00	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.03	1.08	1.62	0.54	0.27	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.07	2.27	2.04	0.23	0.68	0.23	0.45	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.52	1.31	1.96	0.33	0.33	0.00	0.00	1.47
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.89	2.37	2.37	0.73	0.18	0.00	0.00	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.70	1.59	2.12	1.06	0.53	0.00	0.00	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.21	1.80	1.80	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.74	1.97	0.98	0.98	0.33	0.00	0.00	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	29.27	0.98	2.11	0.00	0.16	0.16	0.16	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	40.22	1.23	3.17	0.71	0.71	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	24.61	2.81	2.11	0.70	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	27.58	0.92	0.92	0.00	0.00	0.00	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.53	2.25	1.93	0.00	0.32	0.32	0.32	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.52	2.76	0.69	0.34	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.00	3.12	3.34	1.11	0.45	0.00	0.89	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.75	0.85	1.69	0.00	0.85	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.97	1.19	2.85	0.47	0.00	0.24	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.61	0.86	2.15	0.86	0.43	0.00	0.00	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.66	1.00	1.67	0.33	0.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.46	2.25	5.41	0.00	0.00	0.00	0.00	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.62	2.38	1.59	0.00	0.79	0.00	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	1.86	0.93	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.62	0.76	2.65	0.76	0.00	0.00	0.00	3.03
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.44	0.65	3.26	0.65	1.30	0.33	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	26.58	1.31	2.18	0.00	0.00	0.00	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	42.06	4.07	5.88	0.90	0.45	0.00	0.00	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	33.51	0.00	2.65	0.00	0.88	0.00	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.93	1.33	0.66	0.00	1.33	0.00	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	26.79	0.99	0.99	0.50	0.50	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.29	0.38	2.30	0.38	0.00	0.00	0.38	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	33.87	1.81	2.72	0.30	0.30	0.30	0.00	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	32.71	1.99	2.65	0.66	0.44	0.22	0.22	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	30.49	0.00	1.36	0.68	2.03	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	31.70	0.00	1.83	1.22	0.61	0.00	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.33	1.89	2.83	0.63	0.63	0.00	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.03	1.21	1.21	0.61	0.00	0.00	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	0.00	2.37	0.00	0.00	0.79	0.00	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	1.13	3.40	0.00	0.00	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	30.44	3.35	4.22	2.11	0.75	0.25	0.25	1.61
Myoblast, donor2	11322-117D8	41.23	4.41	3.84	1.34	0.58	0.19	0.19	1.73
Myoblast, donor3	11398-118D3	37.16	6.39	2.86	5.04	0.50	0.17	0.17	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	27.00	0.29	2.04	0.00	0.15	0.00	0.15	1.31
Natural Killer Cells, donor1	11230-116C6	36.29	0.62	0.31	0.00	0.00	0.00	0.00	2.15
Natural Killer Cells, donor2	11311-117C6	34.98	0.90	1.81	0.00	0.00	0.00	0.60	1.81
Natural Killer Cells, donor3	11387-118C1	36.44	1.47	1.29	0.00	0.00	0.00	0.18	2.39
Neural stem cells, donor1	11275-116H6	60.25	1.81	5.08	0.73	0.73	0.73	0.00	2.90
Neural stem cells, donor2	11352-117H2	69.32	3.85	5.78	1.93	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	79.65	1.14	5.69	2.28	0.00	0.00	1.14	4.55
Neurons, donor2	11574-120E8	83.00	4.84	7.49	1.54	0.00	0.88	0.22	3.96
Neurons, donor3	11655-122E8	74.82	4.11	4.93	1.64	0.00	4.11	0.00	3.29
Neutrophils, donor1	11233-116C9	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.00	0.61	0.00	0.00	0.00	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	34.20	2.49	1.78	1.31	0.00	0.00	0.00	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	43.63	2.60	3.58	0.98	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	38.91	3.81	2.21	0.80	0.40	0.20	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	36.75	2.06	2.48	1.51	0.00	0.41	0.00	1.24
Olfactory epithelial cells, donor2	11934-125I8	38.21	2.32	3.18	1.59	0.43	0.29	0.14	1.59
Olfactory epithelial cells, donor3	11935-125I9	37.68	2.16	2.27	1.25	0.11	0.00	0.23	1.14
Olfactory epithelial cells, donor4	11936-126A1	39.25	2.34	3.99	0.88	0.19	0.10	0.10	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	38.52	6.62	6.62	1.20	0.00	0.00	0.00	3.01
Osteoblast - differentiated, donor1	11276-116H7	39.14	1.70	2.34	0.85	0.64	0.00	0.00	1.06
Osteoblast - differentiated, donor2	11353-117H3	24.01	4.57	0.00	0.00	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	38.48	3.10	1.24	2.48	0.62	0.00	0.00	1.24
Osteoblast, donor1	11277-116H8	56.09	6.06	4.50	2.15	0.20	0.20	0.00	2.35
Osteoblast, donor2	11354-117H4	37.22	2.81	2.11	0.70	1.40	0.00	0.00	2.11
Osteoblast, donor3	11426-118G4	44.43	4.98	3.38	3.38	0.00	0.00	0.18	2.13
Pancreatic stromal cells, donor1	11249-116E7	32.09	2.27	2.02	0.51	0.08	0.00	0.08	1.35
Pericytes, donor1	11491-119E6	69.99	5.56	6.23	1.11	0.33	0.45	0.00	1.56
Pericytes, donor2	11571-120E5	66.55	7.24	6.56	3.40	0.23	0.23	0.00	1.36
Pericytes, donor3	11652-122E5	59.81	7.53	7.73	4.88	1.02	0.41	0.00	1.22
Perineurial Cells, donor1	11499-119F5	47.36	7.57	3.84	4.41	0.00	0.23	0.00	1.58
Perineurial Cells, donor2	11579-120F4	42.88	5.24	2.02	2.21	0.09	0.09	0.09	1.93
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	36.97	0.64	1.27	0.32	0.00	0.00	0.32	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.98	0.49	0.73	0.00	0.00	0.00	0.24	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.69	0.39	0.52	0.13	0.13	0.00	0.26	1.16
Placental Epithelial Cells, donor1	11278-116H9	52.62	10.28	6.70	4.30	0.48	0.48	0.48	2.15
Placental Epithelial Cells, donor2	11355-117H5	63.21	15.52	11.09	8.87	1.11	1.11	0.00	5.54
Placental Epithelial Cells, donor3	11427-118G5	54.19	13.35	8.25	7.26	0.79	0.79	0.00	2.55
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	46.20	2.85	1.27	2.53	0.63	0.32	0.00	1.27
Preadipocyte - breast, donor1	11467-119B9	36.02	2.44	3.75	0.38	0.19	0.38	0.00	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	39.55	2.48	2.61	1.17	0.00	0.13	0.13	1.57
Preadipocyte - breast, donor2	11328-117E5	40.08	3.15	2.93	1.80	0.45	0.23	0.00	2.25
Preadipocyte - omental, donor1	11468-119C1	32.18	1.92	3.20	0.96	0.43	0.11	0.11	1.60
Preadipocyte - omental, donor2	11329-117E6	36.66	5.67	3.06	2.18	0.44	0.00	0.00	3.06
Preadipocyte - omental, donor3	11403-118D8	31.51	3.87	4.44	2.86	0.72	0.29	0.00	1.43
Preadipocyte - perirenal, donor1	11469-119C2	38.39	6.89	3.94	4.92	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	44.53	9.21	3.38	2.76	1.23	0.00	0.00	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	46.75	6.91	4.07	3.72	0.35	0.00	0.00	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	38.14	5.96	4.09	2.72	0.68	0.00	0.00	1.36
Preadipocyte - visceral, donor1	11280-116I2	43.13	3.07	2.61	2.89	0.75	0.00	0.00	1.40
Preadipocyte - visceral, donor2	11357-117H7	32.21	2.30	2.30	2.76	0.00	0.00	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	42.84	7.00	2.93	3.03	0.31	0.00	0.00	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	13.43	1.81	2.41	0.91	0.60	0.45	0.00	0.30
Prostate Epithelial Cells, donor2	11331-117E8	29.25	5.96	3.79	2.71	0.41	0.27	0.14	1.35
Prostate Epithelial Cells, donor3	11404-118D9	20.94	1.96	2.57	0.49	0.12	0.00	0.18	0.24
Prostate Stromal Cells, donor1	11254-116F3	31.78	2.85	1.82	1.48	0.46	0.00	0.00	1.03
Prostate Stromal Cells, donor2	11332-117E9	40.70	1.61	2.15	1.97	0.18	0.18	0.00	0.54
Prostate Stromal Cells, donor3	11405-118E1	33.79	4.80	2.50	2.19	0.31	0.21	0.00	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	68.25	5.11	6.20	4.38	0.36	0.73	0.00	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	41.93	3.74	4.16	2.29	0.14	0.21	0.00	1.04
Renal Epithelial Cells, donor1	11517-119H5	108.55	11.67	11.67	7.10	0.51	2.54	0.00	4.06
Renal Epithelial Cells, donor2	11597-120H4	66.86	5.69	9.25	3.56	0.00	1.42	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	42.66	2.96	4.23	1.80	0.42	0.11	0.11	1.91
Renal Glomerular Endothelial Cells, donor1	11514-119H2	78.30	11.57	7.49	11.57	1.36	0.68	0.00	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	63.47	14.42	5.39	9.84	1.75	0.67	0.00	2.16
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.74	7.55	5.11	4.00	1.11	0.00	0.00	2.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	64.55	5.99	4.66	11.31	0.00	0.67	0.00	3.33
Renal Mesangial Cells, donor1	11518-119H6	78.35	7.04	7.26	5.50	0.44	1.32	0.22	2.64
Renal Mesangial Cells, donor2	11598-120H5	82.76	5.02	6.90	2.51	0.00	0.63	0.00	3.76
Renal Mesangial Cells, donor3	11679-122H5	60.75	5.83	8.88	1.94	1.11	0.00	0.00	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	61.20	5.37	8.86	3.49	0.27	0.27	0.00	4.56
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	51.45	3.37	7.59	0.84	0.00	0.84	0.00	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	68.65	6.17	8.68	4.05	0.96	0.00	0.19	2.89
Retinal Pigment Epithelial Cells, donor0	11215-116A9	47.97	3.63	7.00	1.04	1.04	0.26	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	64.81	4.26	7.11	0.85	0.28	0.85	0.28	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	69.98	4.12	6.17	1.03	0.00	0.00	1.03	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	53.95	0.50	2.26	0.00	0.00	0.00	0.00	3.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	33.68	1.60	1.20	0.27	0.00	0.13	0.00	1.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	61.64	1.79	9.83	0.00	0.89	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	27.52	0.55	0.55	0.00	0.00	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	62.65	0.58	5.22	0.00	0.00	0.00	0.58	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	60.20	2.47	3.90	0.39	0.00	0.39	0.00	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	57.90	2.68	6.36	0.20	0.30	0.50	0.00	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	65.36	2.23	3.68	1.45	0.33	0.89	0.11	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	62.64	4.84	5.95	0.62	0.62	0.25	0.00	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	63.28	2.45	5.48	1.17	0.47	0.35	0.12	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	66.80	1.39	7.86	1.39	0.23	0.46	0.00	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	55.31	2.60	4.79	1.37	0.00	0.14	0.00	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	54.46	2.57	5.45	0.30	0.61	0.30	0.00	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	66.48	3.05	4.48	1.25	0.36	0.36	0.18	3.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	60.68	2.87	3.73	0.29	0.29	0.29	0.00	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	59.24	2.68	4.72	0.97	0.00	0.54	0.00	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	60.19	4.20	6.42	0.66	0.22	0.00	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	58.88	3.25	4.78	1.15	0.00	0.19	0.00	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	55.62	2.70	6.24	0.84	0.37	0.19	0.00	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.43	1.50	4.70	1.32	0.38	0.00	0.19	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.80	2.52	4.51	0.27	0.27	0.27	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	58.40	2.92	6.52	0.88	0.39	0.49	0.00	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	62.25	4.01	7.45	0.19	0.38	0.38	0.00	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	57.78	3.63	4.59	0.64	0.32	0.64	0.00	2.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	58.86	1.12	7.85	1.68	0.84	0.00	0.00	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	46.83	3.08	5.81	1.20	0.34	0.17	0.17	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	55.61	2.55	3.83	0.55	0.18	0.00	0.18	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	62.67	2.45	6.74	0.86	0.37	0.37	0.25	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	68.64	2.42	8.46	1.07	0.27	0.40	0.13	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	70.76	2.36	5.90	0.00	0.47	0.24	0.00	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	64.88	2.18	5.36	0.79	0.60	0.40	0.00	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	61.27	3.74	6.31	1.17	0.23	0.23	0.00	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	63.04	2.90	4.15	1.66	0.41	0.00	0.00	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.96	1.77	3.98	1.11	0.44	0.44	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	62.67	1.46	5.85	1.25	0.00	0.42	0.21	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	60.70	3.63	5.65	0.94	0.13	0.13	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	58.07	1.53	5.79	0.00	0.68	0.17	0.17	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	60.54	4.05	5.01	0.39	0.58	0.19	0.00	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	62.24	1.72	4.13	0.34	0.17	0.00	0.00	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	50.34	1.92	4.53	0.82	0.27	0.41	0.00	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	51.71	1.64	6.07	0.99	1.31	0.16	0.16	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	59.99	2.39	4.77	0.34	0.00	0.17	0.00	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	58.74	3.70	5.92	1.04	0.15	0.74	0.00	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	54.38	4.80	4.00	0.53	0.27	0.27	0.00	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	76.18	2.49	4.56	0.14	0.14	1.11	0.00	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	67.14	2.62	7.86	0.71	0.00	0.48	0.00	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	68.12	3.83	7.46	1.41	0.20	0.81	0.20	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	69.41	3.86	5.84	0.66	0.09	0.57	0.00	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	79.31	1.40	6.29	0.35	0.00	0.00	0.00	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	53.79	1.81	5.74	0.00	0.30	0.60	0.00	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	71.11	3.79	5.87	0.86	0.00	0.12	0.00	2.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	102.18	1.89	9.32	0.58	0.44	0.73	0.00	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	57.19	1.83	8.52	0.00	0.00	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.87	1.51	6.03	0.00	0.30	0.30	0.00	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	76.00	1.58	8.37	0.68	0.23	0.68	0.00	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	86.87	4.49	8.39	0.30	0.30	1.50	0.00	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	72.26	3.66	5.43	0.47	0.12	0.94	0.12	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.82	2.35	8.75	0.85	0.00	0.64	0.21	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	69.11	4.81	6.01	0.00	0.00	0.60	0.00	3.61
Schwann Cells, donor1	11498-119F4	84.26	5.45	6.02	2.82	0.19	0.19	0.00	1.32
Schwann Cells, donor2	11578-120F3	44.23	0.00	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	40.31	3.94	4.16	1.10	0.00	0.00	0.44	0.44
Sebocyte, donor1	11220-116B5	61.35	7.67	8.76	3.29	0.00	0.55	0.00	1.64
Sebocyte, donor2	11301-117B5	31.25	6.89	4.60	0.46	0.92	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	42.46	5.36	4.53	0.62	0.21	0.00	0.21	0.21
Sertoli Cells, donor1	11255-116F4	74.55	1.66	3.31	0.00	3.31	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	53.66	5.65	2.82	0.00	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	58.42	2.20	4.57	1.32	0.97	0.35	0.09	1.67
Skeletal Muscle Cells, donor2	11358-117H8	59.27	9.40	3.61	2.89	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	86.95	11.70	6.69	6.69	0.84	1.67	0.84	2.51
Skeletal Muscle Cells, donor4	11451-119A2	45.24	4.71	4.87	1.73	0.94	0.16	0.00	0.94
Skeletal Muscle Cells, donor5	11455-119A6	48.01	5.35	4.31	2.68	0.59	0.30	0.00	2.82
Skeletal Muscle Cells, donor6	11459-119B1	51.40	5.54	4.16	2.77	0.92	0.15	0.00	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	51.91	3.40	3.28	1.64	0.25	0.63	0.00	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	52.65	4.57	3.00	2.57	0.29	0.43	0.14	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	51.29	7.04	7.64	3.87	0.60	0.60	0.00	2.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	49.62	4.72	4.63	4.38	2.95	0.17	0.17	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	64.41	6.51	6.51	2.90	0.72	0.00	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	39.49	7.16	2.34	2.61	0.96	0.41	0.00	1.51
Skin - palm, donor1	10286-104F7	18.80	0.00	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.13	1.30	1.59	1.01	0.29	0.00	0.14	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	80.15	1.64	6.54	0.00	0.00	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.04	1.43	2.86	1.17	0.13	0.13	0.00	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	35.31	1.81	2.09	1.25	0.42	0.00	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	34.60	1.83	5.63	1.13	0.28	0.42	0.00	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	74.85	6.77	7.82	2.11	0.42	1.27	0.42	2.75
Small Airway Epithelial Cells, donor3	11406-118E2	31.33	1.87	3.15	1.50	0.07	0.15	0.07	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	45.67	8.02	4.63	3.09	0.00	0.00	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	44.24	4.45	2.00	1.11	0.44	0.00	0.67	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	52.90	5.88	5.29	2.94	1.18	0.59	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.72	2.65	3.76	1.77	0.66	0.00	0.22	2.43
Smooth Muscle Cells - Aortic, donor2	11360-117I1	43.32	7.09	5.12	3.54	1.97	0.39	0.00	2.36
Smooth Muscle Cells - Aortic, donor3	11432-118H1	43.26	6.18	2.32	3.09	1.55	0.00	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	3.00	5.00	1.00	0.00	0.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	35.80	3.73	5.32	1.60	0.27	0.27	0.00	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.80	1.55	3.10	1.33	0.00	0.00	0.22	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.03	3.71	2.43	2.56	0.51	0.13	0.00	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	44.61	2.28	5.21	1.63	0.33	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.48	5.91	5.91	0.59	1.18	0.30	0.00	3.84
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.59	4.70	3.13	1.00	0.28	0.14	0.00	1.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	65.56	6.34	3.90	2.77	0.81	0.00	0.16	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	31.66	2.13	2.13	0.30	0.00	0.00	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.22	3.79	3.03	0.76	0.51	0.25	0.00	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	18.36	6.12	0.00	0.00	6.12	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	40.05	3.81	3.81	0.00	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	33.33	2.21	2.65	1.47	0.29	0.00	0.00	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	39.17	4.30	4.74	1.08	0.22	0.43	0.00	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.15	2.94	4.41	1.47	0.52	0.10	0.00	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	49.81	6.03	2.94	4.02	1.08	0.31	0.31	2.94
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	39.88	2.16	4.31	1.08	0.00	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.99	6.28	4.18	1.79	0.60	0.30	0.00	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	74.43	6.83	6.83	4.44	1.71	0.00	0.00	3.76
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	51.75	2.98	3.14	1.10	0.16	0.16	0.16	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.71	2.52	1.81	1.01	0.50	0.20	0.00	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.99	3.64	2.96	2.28	0.23	0.00	0.23	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	40.46	8.45	3.02	6.04	0.60	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	46.63	7.15	2.91	1.85	0.26	0.26	0.26	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	32.36	2.40	2.13	1.46	0.00	0.00	0.00	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	29.43	3.01	2.25	0.63	0.38	0.13	0.13	2.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.20	2.54	1.78	0.00	0.00	0.25	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	41.16	3.32	3.02	3.17	0.60	0.00	0.00	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.76	4.50	3.75	1.50	0.00	0.75	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	33.60	3.88	5.17	7.75	0.00	0.00	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	56.74	5.58	4.65	3.26	0.00	0.47	0.47	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	39.38	3.53	4.54	0.50	1.01	0.00	0.00	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	31.03	1.88	1.88	1.25	0.00	0.31	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	35.40	5.31	3.24	2.06	0.29	0.29	0.00	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.07	4.92	2.67	1.42	0.08	0.17	0.17	1.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	36.44	2.34	2.80	1.87	0.00	0.47	0.00	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	30.65	5.61	5.32	2.45	0.72	0.72	0.14	2.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	43.34	8.67	5.35	3.57	0.25	0.00	0.00	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	38.92	5.83	0.75	2.82	0.19	0.19	0.00	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	36.19	3.63	2.52	1.54	0.14	0.28	0.14	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	38.12	7.37	4.44	4.94	0.34	0.59	0.00	2.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	49.05	1.43	3.33	1.90	0.48	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	35.48	6.85	4.16	1.96	1.22	0.00	0.24	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	27.40	1.77	3.76	1.99	0.44	0.00	0.00	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.35	3.22	2.93	1.17	0.29	0.00	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.93	0.78	3.11	0.00	0.00	0.00	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.62	1.32	1.85	1.06	0.00	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.13	0.37	0.00	0.37	0.00	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	35.22	1.80	2.87	1.08	0.00	0.00	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.53	1.42	2.56	0.57	0.57	0.00	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	44.11	0.39	0.79	0.00	0.00	0.00	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	24.38	1.78	2.03	0.00	0.00	0.25	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	21.56	0.40	1.20	0.40	0.00	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	26.33	0.84	2.09	0.42	0.42	0.42	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	27.96	1.38	2.29	0.00	0.00	0.00	0.00	1.38
Synoviocyte, donor1	11291-117A4	40.40	2.52	4.54	1.85	0.50	0.34	0.00	1.35
Synoviocyte, donor2	11368-117I9	35.03	2.01	3.86	1.17	0.00	0.00	0.34	1.34
Synoviocyte, donor3	11440-118H9	36.42	1.34	2.46	0.67	0.22	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	57.53	7.50	7.50	2.86	0.00	0.71	0.00	4.29
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	7.93	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	69.70	6.71	5.79	3.01	0.23	0.23	0.23	2.32
Tracheal Epithelial Cells, donor1	11292-117A5	37.85	2.29	4.30	1.00	0.22	0.00	0.14	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	32.47	2.32	2.32	1.55	0.39	0.39	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	2.29	4.01	2.29	0.57	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.08	2.34	2.21	0.86	0.00	0.25	0.37	1.11
Urethra, donor2	10319-105A4	43.16	0.00	0.00	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	43.83	6.11	2.39	2.39	0.00	0.53	0.00	1.33
Urothelial Cells, donor2	11600-120H7	34.85	3.61	5.21	1.20	0.00	0.40	0.00	0.80
Urothelial Cells, donor3	11681-122H7	38.74	4.13	4.35	1.15	0.23	0.00	0.23	0.92
Urothelial cells, donor0	11216-116B1	36.11	4.01	2.67	1.78	0.00	0.00	0.00	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	64.95	0.00	0.89	0.00	0.00	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	47.18	1.43	0.00	0.00	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	20.54	1.37	0.68	0.00	0.00	0.00	0.00	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	35.47	0.00	0.34	0.34	0.00	0.00	0.34	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.67	1.16	0.58	0.58	0.00	0.00	0.00	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	37.48	0.00	0.00	0.00	0.00	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	29.37	0.00	0.92	0.92	0.00	0.00	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	0.00	2.74	0.00	0.00	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	41.33	5.43	4.81	3.58	0.37	0.49	0.12	3.08
Wilms' tumor cell line:HFWT	10597-108E3	38.72	7.04	7.04	0.00	0.88	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	17.88	0.56	0.84	0.00	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	10.33	0.00	6.20	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	49.46	2.29	6.88	1.53	0.00	1.27	0.25	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	51.54	2.32	3.95	0.23	0.00	0.46	0.00	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	59.24	1.19	3.21	0.24	0.12	0.47	0.00	3.56
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	44.35	4.35	2.18	2.72	0.00	0.00	0.00	11.70
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	53.97	4.78	4.50	4.22	0.00	0.28	0.28	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	37.64	0.63	1.90	0.42	0.00	0.00	0.21	2.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	45.19	0.27	4.36	0.00	0.00	0.27	0.00	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	23.79	1.76	1.32	1.32	0.88	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	37.98	0.82	4.90	0.41	0.41	0.00	0.00	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.87	0.39	1.94	0.00	0.00	0.00	0.00	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.02	0.74	2.21	0.18	0.18	0.00	0.00	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	0.00	7.80	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	34.86	3.72	2.79	2.32	0.23	0.70	0.00	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	41.17	0.00	2.85	0.00	0.26	0.00	0.00	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	39.45	0.58	1.17	0.58	0.00	0.29	0.29	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.93	0.00	0.46	0.00	0.00	0.00	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.04	0.41	0.82	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.58	0.00	1.53	0.00	0.00	0.00	0.00	3.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.15	0.00	3.84	0.00	0.43	0.00	0.00	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	34.88	0.00	1.82	0.00	0.00	0.30	0.00	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	46.70	0.72	2.17	0.00	0.00	0.24	0.00	2.65
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	22.72	0.45	0.89	0.00	0.00	0.45	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	27.02	0.33	1.33	0.33	0.00	0.33	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	76.19	7.43	7.43	0.00	1.86	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	49.72	3.01	4.52	6.40	0.00	0.38	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.78	0.00	2.62	0.00	0.00	0.00	0.00	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	71.23	1.87	11.25	0.00	1.87	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	37.92	1.88	4.71	0.71	0.71	0.24	0.24	1.65
adipose tissue, adult, pool1	10010-101C1	36.92	1.55	1.24	0.93	0.00	0.00	0.16	1.40
adipose, donor1	10184-103D4	43.39	1.76	8.80	0.59	0.00	0.59	0.00	1.17
adipose, donor2	10185-103D5	47.45	1.62	7.30	0.41	0.41	0.41	0.00	0.81
adipose, donor3	10186-103D6	58.27	2.72	7.90	0.54	0.54	0.54	0.00	1.63
adipose, donor4	10187-103D7	31.20	0.00	9.53	1.73	0.87	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	45.93	1.10	2.53	0.47	0.00	0.16	0.00	2.37
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	14.94	0.13	0.53	0.00	0.00	0.00	0.13	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	37.87	2.50	3.57	0.71	0.00	0.00	0.71	3.57
amniotic membrane cells, donor1	12235-129G3	42.66	3.48	3.25	0.00	0.00	0.23	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	29.75	5.07	4.40	2.03	0.34	0.00	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	35.94	2.06	1.77	0.88	0.00	0.29	0.29	1.18
amygdala - adult, donor10196	10167-103B5	48.62	2.37	1.19	0.00	2.37	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	56.17	9.53	8.31	3.65	0.20	0.20	0.20	2.03
amygdala, newborn, donor10223	10360-105E9	35.83	0.65	2.90	1.61	0.65	0.65	0.65	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	43.67	2.93	4.20	1.15	0.00	0.38	0.00	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.14	1.32	2.65	0.00	0.00	0.00	0.22	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	71.15	2.00	13.70	3.67	1.00	0.67	0.00	3.67
aorta, adult, pool1	10052-101G7	32.75	0.98	1.57	0.78	0.00	0.00	0.00	1.77
appendix, adult	10189-103D9	46.96	0.39	4.27	0.78	0.39	0.00	0.39	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	34.05	3.44	3.44	2.06	0.00	0.34	0.00	3.78
artery, adult	10190-103E1	103.26	8.15	20.38	10.87	10.87	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	44.62	7.39	5.22	4.20	1.88	0.72	0.00	2.03
b cell line:RPMI1788	10427-106D4	23.49	1.93	1.34	0.74	0.15	0.00	0.15	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	38.29	10.54	4.99	5.27	0.28	0.00	0.00	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	39.00	1.09	3.27	0.40	0.20	0.10	0.10	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	20.75	0.17	0.67	0.17	0.17	0.00	0.33	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	37.47	0.00	2.80	0.00	0.00	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	36.94	1.74	1.09	0.87	0.11	0.11	0.11	0.65
blood, adult, pool1	10053-101G8	19.93	0.00	2.21	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	2.57	2.57	0.00	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	45.89	0.67	2.70	0.00	0.00	0.67	0.00	1.35
brain, adult, donor1	10084-102B3	87.13	3.08	6.15	2.05	0.00	0.00	2.05	0.00
brain, adult, pool1	10012-101C3	59.58	1.89	6.46	1.56	0.78	0.11	0.33	1.67
brain, fetal, pool1	10085-102B4	120.21	13.36	16.03	0.00	0.00	0.00	0.00	5.34
breast carcinoma cell line:MCF7	10482-107A5	37.99	0.99	2.31	0.66	0.00	0.00	0.33	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	39.82	1.75	2.75	0.12	0.00	0.25	0.00	0.87
breast, adult, donor1	10080-102A8	27.78	1.26	2.53	0.00	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.25	2.16	2.16	1.27	0.13	0.25	0.13	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.67	4.33	3.71	1.86	0.62	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	27.86	2.76	0.46	1.84	0.00	0.00	0.00	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	27.11	4.84	3.39	0.24	0.48	0.24	0.24	1.45
carcinoid cell line:NCI-H1770	10703-109H1	36.67	4.23	6.11	1.41	0.47	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	43.97	1.09	6.45	0.33	0.22	0.55	0.00	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	50.39	4.75	10.14	0.95	0.00	0.32	0.00	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	65.75	3.99	3.73	0.80	0.00	0.27	0.00	1.60
caudate nucleus - adult, donor10196	10177-103C6	57.57	1.15	2.30	0.00	0.00	0.00	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	65.09	9.70	6.69	3.35	0.00	0.84	0.17	1.84
caudate nucleus, adult, donor10258	10379-105H1	103.16	1.53	11.46	3.82	0.00	0.76	0.76	2.29
caudate nucleus, newborn, donor10223	10354-105E3	48.71	3.30	4.03	1.10	1.46	0.00	0.37	1.10
cerebellum - adult, donor10196	10173-103C2	69.92	0.00	5.83	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	81.99	1.92	6.62	0.64	0.00	0.21	0.64	1.92
cerebellum, adult, pool1	10083-102B2	76.58	1.72	3.79	0.00	0.00	0.00	0.00	1.72
cerebellum, newborn, donor10223	10357-105E6	71.40	0.83	4.98	0.00	0.00	0.00	0.00	4.15
cerebral meninges, adult	10188-103D8	65.56	2.02	7.06	0.76	0.25	0.25	0.50	1.26
cerebrospinal fluid, donor2	10294-104G6	34.35	2.92	5.85	2.92	0.73	0.00	0.00	2.92
cervical cancer cell line:D98-AH2	10552-107I3	38.10	1.29	3.45	0.58	0.29	0.29	0.00	1.01
cervical cancer cell line:ME-180	10553-107I4	32.81	0.83	3.15	0.33	0.00	0.17	0.17	0.50
cervix, adult, pool1	10013-101C4	60.79	1.89	1.99	0.52	0.10	0.52	0.10	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	36.92	3.90	4.04	1.25	0.14	0.70	0.28	3.20
chondrosarcoma cell line:SW 1353	10700-109G7	43.11	2.61	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	47.97	3.36	5.34	0.62	0.12	0.25	0.00	0.99
choriocarcinoma cell line:SCH	10785-110H2	18.85	1.85	0.99	0.49	0.00	0.00	0.00	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	51.47	9.49	5.46	1.90	0.00	0.71	0.00	1.66
chorionic membrane cells, donor1	12238-129G6	25.93	5.70	1.14	1.42	0.00	0.28	0.28	0.85
chorionic membrane cells, donor2	12239-129G7	35.50	5.67	3.68	1.39	0.20	0.10	0.10	0.99
chorionic membrane cells, donor3	12240-129G8	32.42	3.85	2.20	0.55	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	28.27	1.01	5.05	1.01	0.00	0.00	0.00	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.89	3.84	2.11	3.27	0.38	0.00	0.19	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	46.88	4.65	8.03	3.38	2.11	0.63	0.21	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.88	1.54	1.28	0.77	0.26	0.00	0.00	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	27.33	1.45	1.45	0.48	0.24	0.24	0.00	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.53	1.63	1.63	0.61	0.41	0.00	0.00	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	49.17	1.47	1.47	1.18	0.00	0.00	0.00	2.65
chronic myelogenous leukemia cell line:KU812	10409-106B4	58.64	3.65	3.91	2.61	1.30	0.26	0.00	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	27.89	2.29	2.29	0.69	0.00	0.00	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	26.03	1.04	3.12	0.00	0.00	0.52	0.00	0.69
colon carcinoma cell line:CACO-2	10513-107D9	14.28	4.39	2.01	1.83	0.37	0.18	0.00	2.38
colon carcinoma cell line:COLO-320	10420-106C6	50.55	3.80	6.08	1.90	0.00	0.76	0.00	0.76
colon, adult, donor1	10082-102B1	66.64	0.00	5.95	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	56.87	2.70	2.94	1.29	0.24	0.00	0.00	1.29
colon, fetal, donor1	10070-101I7	37.08	1.85	1.24	0.00	0.62	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	160.42	0.00	13.75	4.58	0.00	0.00	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.92	0.00	0.42	0.85	0.00	0.00	0.00	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	18.11	0.75	0.45	0.45	0.15	0.15	0.00	3.77
cord blood derived cell line:COBL-a untreated	10449-106F8	20.31	1.55	0.85	1.41	0.00	0.00	0.14	3.38
corpus callosum, adult, pool1	10042-101F6	67.66	2.87	5.20	1.33	0.33	0.44	0.22	1.88
cruciate ligament, donor2	10295-104G7	27.56	0.00	0.81	0.00	1.62	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	47.35	0.00	6.42	0.80	0.00	0.80	0.00	1.61
diencephalon, adult	10193-103E4	45.12	3.84	3.84	1.20	0.00	0.24	0.00	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	27.78	0.00	1.61	0.00	0.00	0.00	0.00	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	23.59	0.26	1.80	0.26	0.00	0.00	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	37.55	6.02	2.65	2.65	0.72	0.96	0.00	1.20
ductus deferens, adult	10196-103E7	37.87	2.99	3.99	1.00	0.00	0.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	2.88	7.20	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	0.74	5.15	0.74	0.74	0.74	0.00	1.47
dura mater, adult, donor1	10041-101F5	23.95	1.98	0.66	0.58	0.17	0.00	0.17	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	42.42	1.11	4.00	0.00	1.78	0.89	0.00	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	34.96	2.01	2.15	0.43	0.14	0.14	0.00	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	26.51	3.70	1.23	1.23	0.00	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	24.22	1.21	1.82	2.12	0.00	0.00	0.00	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.65	4.32	2.16	0.93	0.00	0.00	0.00	1.54
embryonic pancreas cell line:2C6	10603-108E9	36.78	2.63	7.88	5.25	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.41	1.01	2.01	0.67	0.00	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.02	3.81	3.62	1.27	0.00	0.18	0.00	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	26.69	4.02	2.89	0.96	0.00	0.32	0.16	0.80
epidermoid carcinoma cell line:A431	10426-106D3	28.12	1.78	3.00	0.44	0.00	0.22	0.00	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	28.82	2.97	4.62	1.76	0.44	0.55	0.11	0.66
epididymis, adult	10197-103E8	45.00	3.14	3.56	1.47	0.42	0.00	0.42	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.61	2.66	2.13	1.06	0.35	0.00	0.00	3.19
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.09	0.00	1.97	1.97	0.00	0.00	0.00	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.54	1.83	2.88	0.13	0.13	0.13	0.13	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	22.54	1.38	1.77	0.10	0.10	0.10	0.10	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	22.29	1.12	1.12	0.22	0.00	0.11	0.22	1.46
esophagus, adult, pool1	10015-101C6	44.81	1.70	3.08	0.64	0.00	0.32	0.42	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	51.72	1.63	1.88	0.50	0.00	0.13	0.00	5.13
eye - muscle inferior rectus, donor1	10272-104E2	36.22	2.41	2.41	0.00	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	58.92	4.21	2.10	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	68.46	0.00	5.95	2.98	4.46	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	42.42	1.15	1.15	1.15	0.00	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	33.52	0.00	1.46	0.00	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	42.20	1.27	2.54	0.25	0.76	0.00	0.00	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	26.54	1.15	2.18	0.26	0.13	0.26	0.00	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.24	3.32	2.85	2.85	0.95	0.24	0.00	1.42
frontal lobe, adult, pool1	10040-101F4	69.34	4.60	7.13	2.44	0.19	0.47	0.09	3.10
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	26.72	1.80	3.30	1.50	0.30	0.00	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.44	1.28	1.65	0.46	0.00	0.00	0.18	1.28
gall bladder, adult	10198-103E9	50.22	0.97	3.14	0.00	0.00	0.24	0.00	1.69
gamma delta positive T cells, donor1	11937-126A2	54.22	1.07	2.15	0.54	0.54	0.00	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	46.31	0.37	1.12	0.00	0.00	0.00	0.00	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.33	2.11	5.07	0.63	0.84	0.21	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.66	3.48	3.29	0.58	0.19	0.00	0.00	0.97
gastric cancer cell line:AZ521	10549-107H9	51.97	6.39	3.77	1.15	0.66	0.00	0.16	10.49
gastric cancer cell line:GSS	10560-108A2	22.88	4.58	1.83	0.92	0.00	0.92	0.00	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	43.64	2.28	11.88	0.23	0.46	0.23	0.00	1.14
giant cell carcinoma cell line:LU65	10487-107B1	12.62	0.46	0.23	0.00	0.11	0.00	0.00	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	48.99	3.08	2.10	2.80	0.14	0.28	0.00	2.80
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.68	2.49	4.24	2.00	0.00	0.75	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.63	2.64	2.74	0.95	0.11	0.00	0.11	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	46.06	1.69	3.09	0.84	0.28	0.56	0.28	2.95
glioblastoma cell line:T98G	10485-107A8	27.70	4.19	3.53	2.65	0.22	0.11	0.00	1.43
glioma cell line:GI-1	10413-106B8	35.15	1.46	3.22	1.76	0.00	0.29	0.00	1.76
globus pallidus - adult, donor10196	10175-103C4	48.11	1.46	3.64	0.00	0.73	0.00	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	50.04	4.88	7.08	1.22	0.24	0.73	0.98	4.39
globus pallidus, adult, donor10258	10367-105F7	39.71	0.00	1.37	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	48.50	2.66	2.66	1.07	0.00	0.00	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	166.41	0.00	4.89	2.45	0.00	2.45	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	0.00	0.00	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	28.16	3.20	4.48	0.64	0.64	0.32	0.00	1.92
hIPS +CCl2, biol_rep1	14383-156B9	42.70	2.30	4.59	0.46	0.46	0.92	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	44.81	1.37	5.03	0.00	0.00	0.00	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	51.53	2.58	12.88	0.00	0.00	1.29	0.00	0.64
hIPS, biol_rep1	14380-156B6	57.49	0.00	5.75	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	43.90	2.06	6.86	2.06	0.00	0.69	0.00	2.74
hIPS, biol_rep3	14382-156B8	44.14	2.21	2.21	0.00	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	35.34	1.15	4.88	1.15	0.29	0.86	0.00	2.59
heart - mitral valve, adult	10205-103F7	39.46	0.90	1.49	0.60	0.30	0.00	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	50.73	1.31	4.45	0.26	0.00	0.00	0.00	1.57
heart - tricuspid valve, adult	10207-103F9	41.63	1.67	8.33	3.33	0.83	0.00	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	39.18	2.04	2.86	1.02	0.20	0.20	0.00	1.22
heart, adult, diseased, donor1	10051-101G6	48.54	3.83	3.41	0.85	0.00	0.00	0.00	0.85
heart, adult, pool1	10016-101C7	46.69	1.84	4.60	1.15	0.00	0.00	0.00	2.07
heart, fetal, pool1	10046-101G1	59.45	3.08	4.42	2.77	0.21	0.51	0.10	2.26
hepatic mesenchymal tumor cell line:LI90	10778-110G4	36.10	4.32	4.01	1.23	1.23	0.00	0.00	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	77.30	1.19	9.51	1.19	1.19	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	58.45	14.25	12.15	7.96	1.44	0.99	0.11	4.53
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	68.58	17.84	12.26	8.62	2.43	1.58	0.00	4.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	59.92	15.87	13.64	8.39	2.22	0.91	0.20	3.94
hepatoma cell line:Li-7	10484-107A7	27.92	1.89	2.67	0.56	0.22	0.22	0.00	1.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.45	0.10	1.31	0.00	0.00	0.10	0.00	1.01
hippocampus - adult, donor10196	10169-103B7	40.69	2.84	2.84	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	50.21	7.35	5.92	2.86	0.41	0.61	0.41	2.45
hippocampus, adult, donor10258	10374-105G5	68.22	1.00	4.98	0.50	0.50	0.50	0.50	2.49
hippocampus, newborn, donor10223	10363-105F3	52.87	1.76	2.82	0.00	1.06	1.06	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	76.29	1.22	9.77	0.61	0.00	1.83	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	70.69	1.96	9.62	1.57	0.79	0.39	0.00	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	82.77	0.25	10.66	0.51	0.00	0.25	0.00	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	107.13	0.00	12.97	0.56	0.00	2.26	0.00	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	95.54	0.26	10.33	0.26	0.26	0.77	0.00	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	111.23	0.38	11.01	0.38	0.00	0.38	0.00	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	89.63	0.29	5.26	0.00	1.17	0.88	0.29	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	81.86	0.43	6.46	0.43	0.43	0.86	0.00	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	93.01	0.83	6.67	0.42	0.42	0.83	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	69.62	1.66	8.29	0.00	0.47	0.95	0.00	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.43	1.61	9.64	1.13	0.00	0.16	0.00	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	68.68	0.00	5.39	0.00	0.00	2.02	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	50.39	1.56	9.70	2.35	0.31	0.94	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	51.09	2.95	10.81	0.98	0.49	2.46	0.00	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	47.13	0.00	4.36	2.62	0.00	0.87	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	79.80	2.10	15.08	0.57	0.00	2.48	0.00	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	77.18	2.18	13.52	0.44	0.44	0.87	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	70.47	1.00	12.99	1.00	1.50	1.50	0.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	47.29	1.13	3.20	2.26	0.00	0.94	0.00	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	40.02	0.91	6.82	0.91	0.45	0.91	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.55	0.94	2.51	0.31	0.31	0.63	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	53.56	1.47	6.37	0.49	0.33	0.98	0.00	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.00	1.74	8.13	1.16	0.29	0.58	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	52.91	1.79	6.88	0.30	0.60	1.20	0.30	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	60.97	3.14	9.98	2.22	1.48	1.48	0.00	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	58.77	2.57	13.41	2.00	1.14	0.29	0.00	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	67.78	3.67	11.02	2.04	0.41	1.63	0.41	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	66.90	1.41	10.21	1.76	0.35	1.06	0.00	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	74.12	1.90	9.82	0.95	0.00	0.63	0.00	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	92.60	3.03	12.41	1.51	0.30	1.51	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	58.43	1.03	6.72	0.00	0.00	0.00	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	48.48	0.66	3.32	0.00	0.00	1.33	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	63.11	0.51	4.36	0.26	0.00	1.28	0.00	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.13	2.81	7.41	1.28	0.77	1.02	0.26	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.15	3.03	9.84	0.76	0.00	1.51	0.00	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.05	1.01	8.40	1.34	0.34	0.67	0.00	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	58.69	1.45	12.08	1.93	1.21	1.93	0.00	4.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	59.27	0.89	11.59	0.89	0.45	0.45	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	62.44	1.46	8.78	3.41	1.46	0.98	0.00	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	82.21	2.44	11.31	1.22	1.22	1.53	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	3.25	16.27	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	77.44	0.66	13.57	0.66	0.33	0.99	0.00	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	68.96	0.55	5.47	0.55	0.55	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	67.67	1.09	5.79	0.36	0.00	0.72	0.00	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	71.53	0.36	3.91	0.36	0.36	0.36	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	54.90	0.00	3.58	1.19	1.19	2.39	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	70.69	1.76	8.94	0.95	0.81	0.95	0.14	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	58.46	2.69	4.85	0.81	0.54	1.08	0.00	1.62
immature langerhans cells, donor1	11904-125F5	6.30	0.73	0.24	0.00	0.24	0.00	0.00	0.48
immature langerhans cells, donor2	11905-125F6	18.22	0.00	0.79	0.00	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	87.82	6.15	8.90	3.31	0.76	0.76	0.38	2.56
keratoacanthoma cell line:HKA-1	10791-110H8	40.97	2.28	4.55	0.00	0.65	0.65	0.33	0.98
kidney, adult, pool1	10017-101C8	35.65	3.80	2.30	1.40	0.20	0.30	0.20	1.50
kidney, fetal, pool1	10045-101F9	63.38	3.04	6.72	1.20	0.21	0.35	0.07	2.62
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.09	2.98	4.12	1.85	0.28	0.57	0.00	5.11
large cell lung carcinoma cell line:NCI-H460	10839-111E2	24.47	1.11	1.24	0.41	0.00	0.28	0.00	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.32	1.47	4.04	0.37	0.73	0.55	0.37	1.10
left atrium, adult, donor1	10079-102A7	25.06	2.18	1.09	0.54	0.54	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	23.26	1.01	1.52	0.51	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	68.13	11.77	6.02	7.66	1.09	0.27	0.00	3.83
leiomyoma cell line:10964C	10569-108B2	25.51	2.87	1.08	0.72	0.00	0.00	0.00	1.80
leiomyoma cell line:15242A	10570-108B3	26.63	2.72	1.63	1.09	0.54	0.00	0.00	1.63
leiomyoma cell line:15425	10571-108B4	31.32	2.91	1.46	0.73	0.00	0.00	0.00	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	2.09	4.18	0.00	0.00	0.00	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	33.53	7.91	7.67	5.55	2.72	0.71	0.12	1.06
liposarcoma cell line:KMLS-1	10782-110G8	43.27	1.87	2.97	0.94	0.16	0.00	0.31	1.87
liposarcoma cell line:SW 872	10726-110A6	25.46	3.05	3.66	2.44	0.12	0.61	0.24	1.95
liver, adult, pool1	10018-101C9	28.52	3.40	1.94	0.32	0.00	0.00	0.16	1.13
liver, fetal, pool1	10086-102B5	21.64	0.00	0.94	0.00	0.00	0.94	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	39.23	2.33	3.50	0.58	0.15	0.44	0.29	1.31
locus coeruleus, adult, donor10252	10165-103B3	40.23	6.46	4.43	2.21	0.74	0.18	0.37	1.85
locus coeruleus, adult, donor10258	10375-105G6	58.12	1.41	6.21	0.56	1.13	0.00	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	22.71	0.42	3.36	1.26	0.84	0.84	0.00	1.26
lung adenocarcinoma cell line:A549	10499-107C4	22.70	1.94	1.25	0.28	0.14	0.00	0.14	1.38
lung adenocarcinoma cell line:PC-14	10408-106B3	77.21	7.58	9.65	3.45	0.00	1.38	0.00	4.83
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.54	2.77	2.50	1.85	0.13	0.26	0.00	0.92
lung, adult, pool1	10019-101D1	27.41	2.13	1.65	1.18	0.00	0.24	0.00	1.18
lung, fetal, donor1	10068-101I5	60.22	1.14	2.28	0.57	0.00	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	31.62	1.37	2.75	0.46	0.00	0.00	0.46	1.83
lymph node, adult, donor1	10077-102A5	28.40	0.95	0.95	0.00	0.00	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	20.82	1.10	0.22	0.00	0.22	0.00	0.00	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	18.71	0.45	1.66	0.15	0.00	0.15	0.00	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	30.58	1.70	2.55	0.00	0.85	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	56.83	0.44	1.33	0.00	0.00	0.00	0.44	1.33
mature adipocyte, donor2	12232-129F9	44.62	1.87	2.28	0.21	0.00	0.00	0.62	0.62
mature adipocyte, donor3	12233-129G1	49.31	2.84	1.66	0.24	0.00	0.00	0.24	2.37
mature adipocyte, donor4	12234-129G2	43.17	1.58	1.58	0.26	0.00	0.00	0.00	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.98	1.43	3.57	0.00	0.24	0.48	0.00	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	60.91	1.13	7.90	1.13	0.00	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	57.56	5.33	8.64	1.29	0.37	0.55	0.37	2.02
medial frontal gyrus, adult, donor10258	10368-105F8	52.42	1.27	3.49	1.27	0.32	0.64	0.00	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	27.72	0.85	4.69	0.85	0.00	0.43	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	64.46	3.38	7.93	1.18	0.17	0.34	0.00	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	49.02	7.00	5.52	2.12	0.85	0.64	0.21	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	46.23	1.93	0.00	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	63.53	1.79	5.38	6.46	0.72	0.36	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	29.85	0.65	0.65	0.00	0.00	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	34.52	4.33	4.18	1.08	0.00	0.15	0.46	2.32
medulla oblongata, adult, pool1	10038-101F2	48.89	2.12	5.63	1.39	0.16	0.33	0.41	1.22
medulla oblongata, newborn, donor10223	10361-105F1	43.40	0.00	3.12	0.35	0.00	0.00	0.00	2.08
medulloblastoma cell line:D283 Med	10838-111E1	76.17	2.44	5.31	1.11	0.00	0.44	0.00	3.10
medulloblastoma cell line:ONS-76	10759-110E3	14.43	1.22	1.71	0.98	0.12	0.24	0.00	0.49
melanoma cell line:COLO 679	10514-107E1	13.66	2.44	1.44	0.57	0.00	0.14	0.00	0.43
melanoma cell line:G-361	10465-106H6	25.52	2.17	0.81	0.54	0.27	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	22.79	0.90	1.45	0.00	0.00	0.18	0.18	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	89.88	0.88	9.69	0.00	0.00	0.88	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	92.02	4.41	14.78	3.11	1.04	2.33	0.00	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	39.89	6.75	2.92	2.45	0.15	0.00	0.46	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.90	4.91	2.00	1.45	0.00	0.00	0.00	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.13	3.31	2.90	1.66	0.83	0.00	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	26.27	3.09	0.98	0.84	0.14	0.00	0.14	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.43	3.85	1.73	0.58	0.19	0.19	0.00	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	25.68	1.39	1.39	2.08	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.09	3.43	1.89	1.54	0.00	0.00	0.00	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	32.78	2.42	1.15	0.35	0.00	0.00	0.12	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.71	7.03	3.05	2.12	0.00	0.00	0.00	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	31.19	4.19	3.38	1.22	0.00	0.00	0.14	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	29.31	5.83	2.99	1.85	0.14	0.00	0.14	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.32	1.32	0.66	0.00	0.00	0.00	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	32.38	4.29	2.21	1.80	0.00	0.14	0.14	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.02	5.24	3.49	1.75	0.35	0.35	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	32.87	3.88	2.25	2.04	0.00	0.20	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	34.15	1.80	1.44	1.44	0.36	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.31	7.76	1.76	1.86	0.10	0.00	0.00	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.01	2.51	1.14	1.37	0.23	0.23	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.53	5.03	2.52	1.68	0.42	0.00	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.05	4.93	3.14	1.05	0.00	0.15	0.00	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	35.71	7.44	2.28	1.58	0.00	0.26	0.00	1.23
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.24	4.42	2.21	0.74	0.00	0.00	0.00	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	37.77	1.43	2.86	1.72	0.29	0.29	0.00	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	47.15	8.42	6.74	3.37	1.68	0.00	0.42	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.08	4.11	3.65	0.91	0.91	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.48	1.02	2.81	0.00	0.51	0.00	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.89	2.88	2.36	1.31	0.00	0.26	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.59	2.77	2.46	0.62	0.62	0.00	0.00	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.95	3.53	1.41	0.47	0.24	0.24	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	36.21	3.72	2.71	1.02	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.33	3.14	4.72	1.18	0.39	0.79	0.00	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	32.44	0.00	1.85	1.39	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	45.86	1.73	2.60	2.31	0.00	0.29	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	38.82	2.01	2.68	1.12	0.00	0.22	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	40.38	2.16	2.40	0.96	0.24	0.00	0.24	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.73	2.20	1.47	0.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	35.24	0.67	2.69	0.67	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	34.80	2.46	2.46	0.41	0.00	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.81	1.29	1.29	0.00	0.43	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	0.00	0.00	0.00	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	30.85	1.30	1.95	0.32	0.00	0.00	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	34.92	1.45	1.45	1.45	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	38.38	1.07	3.20	0.00	0.00	0.00	0.00	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	32.71	3.27	2.45	1.64	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.48	1.17	3.11	0.78	0.78	0.00	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	50.37	4.20	0.00	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	1.99	2.98	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	4.77	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	25.50	0.59	1.19	0.00	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	32.90	1.22	3.66	0.00	1.22	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	3.17	3.80	0.63	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.70	0.34	1.72	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	2.15	0.00	2.15	0.00	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.49	1.22	2.44	0.41	0.00	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.98	3.97	3.18	0.79	0.00	0.00	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.19	1.18	4.72	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.42	1.25	6.23	0.31	0.00	0.00	0.00	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	0.00	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	1.18	1.18	0.00	0.00	1.18	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.83	0.69	2.75	0.00	0.00	0.00	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	46.51	0.49	4.45	0.49	0.00	0.00	0.00	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	52.71	3.36	4.49	1.12	0.00	1.12	0.00	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.71	1.27	4.45	0.00	0.00	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	58.03	5.64	5.24	1.21	0.00	0.00	0.40	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	69.78	4.36	4.36	0.00	0.00	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	50.68	7.60	6.34	1.27	1.27	0.00	0.00	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	43.70	4.25	2.43	0.00	1.21	0.00	0.00	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	5.77	3.29	0.82	0.82	0.82	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	37.50	1.59	3.57	0.00	0.00	0.00	0.40	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	43.48	1.95	2.92	0.00	0.00	0.32	0.00	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	44.82	1.02	0.00	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	55.71	6.19	7.74	4.64	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	52.45	4.72	2.36	3.31	0.24	0.00	0.00	2.36
mesothelioma cell line:ACC-MESO-4	10494-107B8	32.20	4.17	1.85	2.55	0.00	0.23	0.23	2.32
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	4.27	4.27	4.27	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	29.80	2.88	2.88	1.03	0.41	0.10	0.00	1.34
mesothelioma cell line:Mero-25	10850-111F4	25.19	0.91	4.31	2.04	0.45	0.00	0.00	0.68
mesothelioma cell line:Mero-41	10851-111F5	49.38	1.96	3.18	0.73	0.00	0.49	0.00	1.22
mesothelioma cell line:Mero-48a	10852-111F6	22.81	2.66	2.66	1.99	1.55	0.00	0.00	0.89
mesothelioma cell line:Mero-82	10853-111F7	43.36	2.89	9.20	2.37	1.31	0.26	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	27.75	3.40	3.23	1.19	0.51	0.68	0.17	2.04
mesothelioma cell line:Mero-84	10855-111F9	29.83	1.77	0.76	1.77	0.51	0.00	0.00	1.77
mesothelioma cell line:Mero-95	10856-111G1	27.12	2.28	2.90	1.45	0.21	0.21	0.00	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	49.53	2.98	6.29	2.98	1.66	0.50	0.17	1.99
mesothelioma cell line:NCI-H226	10846-111E9	34.57	2.90	2.35	2.35	0.54	0.54	0.00	2.71
mesothelioma cell line:NCI-H2452	10848-111F2	16.40	1.88	1.71	0.34	0.00	0.00	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	40.97	3.05	4.33	1.02	1.27	0.25	0.25	2.80
mesothelioma cell line:No36	10857-111G2	21.86	0.00	1.63	0.00	0.65	0.00	0.00	1.30
mesothelioma cell line:ONE58	10858-111G3	29.26	2.17	3.52	0.81	0.27	0.00	0.54	1.35
migratory langerhans cells, donor1	11901-125F2	22.07	1.34	1.15	0.19	0.00	0.00	0.00	0.96
migratory langerhans cells, donor2	11902-125F3	32.12	2.08	1.59	0.37	0.00	0.00	0.00	1.10
migratory langerhans cells, donor3	11903-125F4	30.15	1.44	1.97	0.54	0.00	0.36	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.32	2.61	3.92	1.31	0.00	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.67	1.91	4.87	1.48	0.00	0.21	0.00	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	43.08	0.46	4.61	0.23	0.00	0.00	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.79	3.04	0.95	1.52	0.19	0.00	0.00	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.81	2.03	3.33	0.55	0.18	0.18	0.18	2.59
myeloma cell line:PCM6	10474-106I6	44.67	0.99	2.37	0.20	0.00	0.00	0.00	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	45.66	3.55	5.07	3.04	0.51	0.51	0.00	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.51	0.39	0.39	0.20	0.00	0.00	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.76	1.67	2.45	0.67	0.00	0.00	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.12	0.81	2.06	0.15	0.00	0.22	0.00	0.59
nasal epithelial cells, donor2	12227-129F4	36.43	3.31	2.76	0.55	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	76.61	3.68	4.83	2.76	0.23	2.07	0.00	3.91
neuroblastoma cell line:NB-1	10539-107G8	72.78	3.74	7.67	3.74	0.94	0.56	0.00	4.86
neuroblastoma cell line:NBsusSR	10607-108F4	53.35	4.43	9.07	0.63	0.00	0.63	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	69.51	5.03	10.06	1.12	0.93	1.30	0.00	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	44.12	1.42	3.32	0.71	0.00	0.47	0.00	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.40	4.91	4.28	0.95	0.00	0.79	0.00	2.69
neuroectodermal tumor cell line:TASK1	10774-110F9	62.99	3.02	6.44	1.01	0.00	0.20	0.00	3.02
neuroepithelioma cell line:SK-N-MC	10728-110A8	47.05	4.45	6.36	1.27	0.00	0.64	0.00	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	42.85	1.86	3.19	1.60	0.00	0.00	0.27	1.33
neutrophil PMN, donor1	12133-128D9	208.25	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	47.86	5.92	6.60	7.10	0.68	0.51	0.00	5.75
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	36.82	7.20	2.40	6.40	0.00	0.00	0.80	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.38	3.85	4.17	0.00	0.32	0.96	0.00	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	31.01	5.78	4.20	1.58	0.79	0.26	0.00	1.84
nucleus accumbens, adult, pool1	10037-101F1	78.93	6.19	6.56	3.19	0.47	0.75	0.19	2.81
occipital cortex - adult, donor10196	10172-103C1	67.99	2.06	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	61.19	6.98	5.90	1.88	0.27	0.00	0.00	1.88
occipital cortex, newborn, donor10223	10355-105E4	58.59	2.18	5.82	2.91	0.73	0.36	0.36	2.18
occipital lobe, adult, donor1	10076-102A4	61.66	3.15	9.45	0.79	0.00	0.00	0.26	2.62
occipital lobe, fetal, donor1	10073-102A1	78.95	3.86	9.44	1.72	0.43	1.29	0.00	1.72
occipital pole, adult, pool1	10036-101E9	75.61	4.89	7.02	1.18	0.39	0.24	0.32	2.60
olfactory region, adult	10195-103E6	59.42	2.48	4.97	1.72	0.38	0.00	0.38	1.15
optic nerve, donor1	10277-104E7	68.04	0.00	2.00	0.00	0.00	0.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	20.16	0.80	1.82	0.11	0.23	0.11	0.11	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.77	3.16	4.95	0.96	0.27	0.14	0.00	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.33	0.51	0.51	0.00	0.00	0.17	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	25.64	1.73	2.54	0.35	0.35	0.12	0.00	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	39.98	2.35	4.70	0.59	0.00	0.29	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	160.71	10.28	19.62	4.67	1.87	1.87	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	32.45	2.12	2.54	1.48	0.64	0.00	0.00	2.76
ovary, adult, pool1	10020-101D2	45.60	1.05	1.66	0.17	0.00	0.09	0.17	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	31.16	0.55	2.20	0.37	0.18	0.00	0.00	1.28
pancreas, adult, donor1	10049-101G4	52.68	1.88	0.94	1.88	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	30.75	2.80	2.24	0.56	0.28	0.28	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	26.75	2.38	2.73	0.85	0.00	0.17	0.00	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.82	1.82	1.99	0.66	0.33	0.00	0.00	0.99
paracentral gyrus, adult, pool1	10035-101E8	70.66	5.49	8.24	2.84	0.37	0.73	0.27	2.11
parietal cortex, adult, donor10258	10373-105G4	53.58	0.73	3.67	0.73	0.73	0.00	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	48.91	0.94	4.70	0.00	0.94	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	54.44	3.14	6.84	1.43	0.00	0.29	0.00	1.71
parietal lobe, adult, pool1	10034-101E7	71.38	4.05	8.99	1.94	0.62	0.62	0.09	3.26
parietal lobe, fetal, donor1	10072-101I9	112.50	5.82	2.91	0.00	0.00	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	51.59	1.50	1.87	2.24	1.50	0.00	0.00	2.62
parotid gland, adult	10199-103F1	41.93	2.47	0.62	0.00	0.00	0.00	0.62	1.23
penis, adult	10200-103F2	39.21	3.76	5.91	1.61	2.69	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.30	0.74	1.12	0.00	0.00	0.37	0.00	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	33.07	3.79	3.35	1.02	0.44	0.29	0.00	0.73
pineal gland - adult, donor10196	10179-103C8	33.54	0.65	3.87	1.29	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	48.56	2.37	3.55	1.78	0.59	0.00	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	34.49	0.00	3.76	1.25	0.00	0.63	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	39.46	3.04	0.00	1.01	0.00	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	60.98	5.73	3.65	1.04	0.00	0.00	0.00	3.65
pituitary gland, adult, donor10258	10378-105G9	41.71	2.55	2.55	1.70	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	37.20	2.04	2.15	0.75	0.11	0.11	0.32	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	24.23	1.32	0.66	0.13	0.13	0.00	0.00	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.18	4.67	3.74	1.56	0.00	0.31	0.16	1.71
pons, adult, pool1	10033-101E6	48.54	2.58	6.20	0.52	0.09	0.43	0.43	1.72
postcentral gyrus, adult, pool1	10032-101E5	75.06	4.18	7.93	1.57	0.61	0.70	0.17	2.01
promyelocytes/myelocytes PMC, donor1	12132-128D8	112.94	0.00	8.37	0.00	0.00	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	26.36	2.04	2.33	1.17	0.15	0.00	0.00	1.31
prostate cancer cell line:PC-3	10439-106E7	41.38	4.36	4.17	2.90	0.73	0.18	0.00	1.63
prostate, adult, pool1	10022-101D4	45.16	1.72	2.09	0.91	0.09	0.36	0.00	1.90
putamen, adult, donor10196	10176-103C5	75.78	8.03	9.91	4.49	1.18	0.71	0.00	2.36
putamen, adult, donor10252	10152-102I8	72.55	3.92	13.73	3.92	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	49.18	2.19	1.09	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	76.59	2.42	4.59	1.45	0.24	0.72	0.00	2.90
putamen, newborn, donor10223	10365-105F5	17.24	0.75	3.00	1.50	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	22.69	0.58	2.91	0.00	0.29	0.29	0.00	0.87
rectum, fetal, donor1	10067-101I4	76.50	0.00	9.74	0.00	1.39	0.00	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	15.05	0.85	1.27	0.21	0.00	0.42	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.56	1.66	0.41	2.49	0.00	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	51.69	1.49	3.68	0.50	0.10	0.00	0.00	0.99
retinoblastoma cell line:Y79	10475-106I7	69.11	4.42	4.42	2.60	0.78	1.04	0.00	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.85	3.32	4.55	1.11	0.25	0.37	0.00	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	111.92	7.87	6.47	2.81	1.12	0.84	0.56	5.91
sacrococcigeal teratoma cell line:HTST	10695-109G2	48.50	6.06	2.27	1.52	0.00	0.76	0.00	1.52
salivary acinar cells, donor1	11771-123I7	23.15	1.94	0.97	1.13	0.00	0.00	0.16	0.49
salivary acinar cells, donor2	11772-123I8	31.81	1.65	2.20	0.41	0.14	0.41	0.14	1.38
salivary acinar cells, donor3	11773-123I9	50.32	2.65	7.28	1.32	0.00	0.00	1.32	1.99
salivary gland, adult, pool1	10093-102C3	31.46	1.72	0.57	1.14	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.64	0.93	2.28	0.42	0.25	0.08	0.25	2.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	50.08	1.76	2.23	0.94	0.47	0.12	0.35	1.06
seminal vesicle, adult	10201-103F3	40.21	0.53	0.53	0.00	0.00	0.53	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	13.85	0.49	1.70	0.49	0.49	0.49	0.00	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	45.29	5.03	3.27	1.76	0.00	0.00	0.50	3.27
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	62.22	2.01	5.02	1.00	0.00	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	53.19	3.63	10.88	1.21	0.27	1.48	0.13	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	26.53	0.55	3.09	0.77	0.11	0.11	0.00	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	30.19	1.16	2.71	0.13	0.13	0.13	0.00	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	105.69	3.55	9.93	3.55	9.22	1.42	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	154.72	20.63	17.15	11.99	10.67	0.96	0.12	2.52
skeletal muscle, fetal, donor1	10066-101I3	67.34	7.04	15.08	5.03	5.03	0.00	0.00	2.01
skin, adult, donor1	10074-102A2	54.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.08	1.89	4.42	1.89	0.63	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	38.02	10.01	7.00	7.67	0.67	0.00	0.00	3.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.49	7.56	8.51	0.95	0.95	0.32	0.00	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	63.03	7.32	2.70	0.96	0.19	0.19	0.00	4.63
small cell lung carcinoma cell line:LK-2	10541-107H1	55.05	2.31	4.62	0.49	0.00	0.99	0.00	2.80
small cell lung carcinoma cell line:NCI-H82	10842-111E5	48.58	1.61	2.41	0.64	0.32	0.32	0.00	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	41.62	4.36	3.92	1.31	0.00	0.44	0.00	2.83
small intestine, adult, pool1	10024-101D6	50.40	1.91	2.99	0.48	0.00	0.12	0.96	1.91
small intestine, fetal, donor1	10064-101I1	35.87	0.49	2.95	0.49	0.00	0.25	0.00	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.88	2.05	5.13	0.00	0.00	0.51	0.00	2.05
smooth muscle, adult, pool1	10048-101G3	45.23	0.78	1.03	0.26	0.00	0.26	0.00	1.29
somatostatinoma cell line:QGP-1	10781-110G7	34.31	3.75	5.90	0.80	0.27	0.54	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	38.31	2.29	2.29	0.46	0.69	0.46	0.00	1.61
spinal cord, adult, donor10252	10159-103A6	27.99	5.13	2.37	1.18	0.00	0.00	0.39	1.18
spinal cord, adult, donor10258	10369-105F9	26.29	1.38	0.69	0.00	0.69	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	55.50	3.66	7.32	1.22	0.00	0.61	0.00	3.05
spinal cord, newborn, donor10223	10359-105E8	35.82	0.46	4.13	0.00	0.00	0.92	0.00	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	43.46	2.84	4.78	1.79	0.45	0.15	0.00	1.79
spleen, adult, pool1	10025-101D7	32.38	1.87	2.09	0.99	0.22	0.00	0.00	2.09
spleen, fetal, pool1	10044-101F8	43.78	2.78	3.26	1.75	0.40	0.08	0.24	2.54
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.22	0.31	0.72	0.41	0.00	0.10	0.21	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.54	1.52	2.66	0.38	0.00	0.19	0.00	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	33.90	2.10	2.10	0.35	0.00	0.00	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	24.24	0.78	3.52	0.00	0.00	0.00	0.00	3.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	27.46	0.34	2.48	0.34	0.00	0.11	0.11	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	1.69	2.12	0.85	0.85	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	59.65	5.08	3.81	0.00	0.00	0.00	0.00	2.12
stomach, fetal, donor1	10062-101H8	69.42	0.00	9.61	2.14	1.07	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	38.74	1.71	1.71	0.00	0.00	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	45.07	3.95	2.91	1.45	0.21	0.00	0.21	2.28
substantia nigra, adult, donor10258	10371-105G2	48.10	1.03	2.07	0.52	0.00	0.00	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	36.74	0.00	1.41	0.71	0.00	0.00	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	35.08	5.96	3.90	3.44	0.23	0.00	0.23	2.98
temporal lobe, adult, pool1	10031-101E4	93.16	5.51	9.16	4.75	0.68	0.51	0.42	3.98
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	85.47	5.70	11.40	3.56	0.00	2.14	0.00	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	102.41	5.27	8.35	1.76	0.44	1.76	0.00	2.64
tenocyte, donor1	11763-123H8	61.09	6.63	2.09	2.44	0.00	0.00	0.00	2.09
tenocyte, donor2	11765-123I1	44.25	6.49	3.82	1.91	0.00	0.00	0.00	2.29
tenocyte, donor3	11768-123I4	58.19	8.15	2.59	1.48	0.74	0.00	0.00	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	43.00	9.18	6.80	3.23	0.85	0.85	0.00	2.72
teratocarcinoma cell line:NCR-G1	10798-110I6	48.40	5.09	10.33	1.85	0.15	0.31	0.00	2.16
teratocarcinoma cell line:PA-1	10807-111A6	50.99	2.63	11.16	1.70	0.15	0.31	0.00	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	25.90	4.19	4.44	1.52	0.13	0.38	0.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	29.12	2.27	1.89	0.00	0.00	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.36	2.84	3.05	2.29	0.11	0.22	0.00	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.77	1.30	4.56	0.65	0.33	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	62.49	1.72	4.94	0.64	0.32	0.32	3.01	7.30
testis, adult, pool2	10096-102C6	76.23	0.45	4.06	0.45	0.45	0.00	2.71	8.57
thalamus - adult, donor10196	10168-103B6	47.47	1.10	2.21	0.00	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	50.01	5.16	4.53	2.19	0.31	0.16	0.00	2.34
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	1.54	1.54	0.00	1.54	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	44.14	0.66	3.29	0.49	0.49	0.16	0.33	0.82
thalamus, newborn, donor10223	10366-105F6	21.86	0.58	3.45	0.00	1.15	1.15	0.58	1.15
throat, adult	10209-103G2	57.42	4.74	8.24	1.50	1.75	0.25	0.00	1.75
throat, fetal, donor1	10061-101H7	58.50	3.96	6.09	0.30	1.83	0.30	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	56.24	7.15	4.97	6.56	0.40	0.79	0.00	3.78
thymus, adult, pool1	10027-101D9	48.71	1.39	1.69	0.40	0.00	0.10	0.00	2.88
thymus, fetal, pool1	10043-101F7	53.61	1.87	2.60	0.62	0.00	0.21	0.00	4.16
thyroid carcinoma cell line:KHM-5M	10776-110G2	44.01	1.86	3.72	1.20	0.13	0.27	0.00	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	33.53	1.54	3.77	0.56	0.28	0.14	0.00	1.26
thyroid, adult, pool1	10028-101E1	56.45	5.04	4.11	1.31	0.19	0.28	0.09	3.17
thyroid, fetal, donor1	10060-101H6	60.12	1.32	4.48	1.58	0.26	0.00	0.26	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	6.16	0.00	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	56.28	2.79	8.14	2.33	1.40	0.00	0.47	0.70
tongue, fetal, donor1	10059-101H5	59.51	3.94	5.52	1.18	0.00	0.79	0.00	1.18
tonsil, adult, pool1	10047-101G2	40.97	1.70	2.70	0.80	0.10	0.10	0.00	1.00
trachea, adult, pool1	10029-101E2	36.24	2.21	1.55	0.57	0.16	0.08	0.00	1.72
trachea, fetal, donor1	10058-101H4	43.47	1.15	0.77	0.00	0.00	0.00	0.00	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.99	1.77	1.06	2.48	0.00	0.35	0.00	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	43.26	1.32	5.78	0.71	0.10	0.10	0.10	1.01
transitional-cell carcinoma cell line:JMSU1	10492-107B6	51.24	4.07	6.42	0.78	1.10	0.47	0.00	2.35
tridermal teratoma cell line:HGRT	10694-109G1	76.10	5.71	9.51	3.81	1.90	0.00	0.00	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	34.62	1.61	2.88	0.93	0.08	0.08	0.00	1.69
umbilical cord, fetal, donor1	10057-101H3	27.12	4.17	0.00	4.17	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	69.10	1.54	2.22	1.02	0.00	0.00	0.17	2.22
uterus, fetal, donor1	10055-101H1	51.19	5.12	5.63	2.56	0.51	0.51	0.00	1.54
vagina, adult	10204-103F6	45.23	1.94	1.29	0.65	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	47.35	1.10	3.29	0.66	0.44	0.00	0.22	2.85
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.31	2.67	1.34	0.53	0.00	0.27	0.00	1.87